.png)
COVID-19 Evidence Reviews
as of 1/17/22
Today's Feature
|
1/12/2022 |
The January newsletter is here! Read about our updates on new content, features, and resources. Sign up below to receive our monthly newsletters directly in your inbox! | |
= living reviewA review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
 latest update date
 |
select |
|
|---|---|---|
|
1/17/22
|
Alharbi MG | Expert Rev Hematol
Aim: To review the evidence on COVID-19 infection associated with ITP.
|
|
|
1/17/22
|
Lan SH, Lee HZ, Chao CM, et al. | J Med Virol
Aim: To investigate the effect of melatonin on clinical outcomes in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
1/17/22
|
Hermansyah TA, Ginanjar E, Putri VH | Acta Med Indones
Aim: To summarize the prognosis of Corona Virus Disease 2019 (COVID-19) patients with elevated troponin and N-terminal pro brain natriuretic peptide (NT-proBNP) levels and demonstrate the involvement of myocardial injury as a complication in COVID-19.
|
|
|
1/17/22
|
Shahzad M, Chaudhary SG, Zafar MU, et al. | Transpl Infect Dis
Aim: To investigate the impactof COVID-19 in HSCT recipients, including the severity of symptoms, treatment modalities used, and prognosis.
|
|
|
1/17/22
|
Danwang C, Noubiap JJ, Robert A, et al. | AIDS Res Ther
Aim: To summarize the available information on the risk of hospitalization, severe disease, and death attributable to HIV in patients with COVID-19 and to determine the proportion of patients co-infected with HIV among patients with COVID-19. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/17/22
|
Singh A, Singh Y, Pangasa N, et al. | Indian J Crit Care Med
Aim: To highlight the risk factors, types, and outcomes of air leak in COVID-19.
|
|
|
1/17/22
|
Cao XJ, Fang KY, Zhou J, et al. | J Virol Methods
Aim: To review the evidence on the performance of commercial Cepheid Xpert Xpress SARS-CoV-2 test for the identification of SARS-CoV-2.
|
|
|
1/14/22
|
Suh S, Lee S, Gym H, et al. | BMC Infect Dis
Aim: To discover the related SNPs of SARS-CoV-2 infection.
|
|
|
1/14/22
|
Rosário Ferreira ME, Santos de Andrade AV, Ferreira Queiroz AA, et al. | EXCLI J
Aim: To review the evidence on the clinical and laboratory characteristics, associated comorbidities, and outcomes of obese patients with COVID-19.
|
|
|
1/14/22
|
Galmiche S, Nguyen LBL, Tartour E, et al. | Clin Microbiol Infect
Aim: To assess immunogenicity, efficacy and effectiveness of COVID-19 vaccines in immunocompromised populations.
|
|
|
1/14/22
|
Kim DH, Basurrah MA, Han JH, et al. | Saudi Med J
Aim: To evaluate the diagnostic utility of self-collected saliva in coronavirus desease-19 (COVID-19) screening procedures.
|
|
|
1/13/22
|
Joshi R, Singla R, Mishra A, et al. | New Microbes New Infect
Aim: To assess the possibility of re-infection in discharged patients and the risk of the transmission, proficiency of RT-PCR results and approximate period required for the quarantine and the real challenges for the development of vaccine.
|
|
|
1/13/22
|
Abbaspur-Behbahani S, Monaghesh E, et al. | Health Policy Technol
Aim: To synthesize the capabilities of m-health in providing health services to the elderly during the COVID-19 pandemic, and to identify the factors contributing to the success of these tools.
|
|
|
1/13/22
|
Jdiaa SS, Mansour R, El Alayli A, et al. | J Nephrol
Aim: To summarize the effect of CKD on different outcomes among patients with COVID–19.
|
|
|
1/13/22
|
Reddy SGK, Mantena M, Garlapati SKP, et al. | J Pharm Bioallied Sci
Aim: To determine the pooled estimations in the clinical features and prognosis along with the subgroups based on the severity of the disease in various regions of the world.
|
|
|
1/13/22
|
Macpherson K, Cooper K, Harbour J, et al. | BMJ Open
Aim: To explore the experiences of people living with long COVID and how they perceive the healthcare services available to them.
|
|
|
1/13/22
|
Zintel S, Flock C, Arbogast AL, et al. | Z Gesundh Wiss
Aim: To investigate whether there are systematic gender differences in the intention to get vaccinated against COVID-19.
|
|
|
1/13/22
|
Soltani S, Zandi M, Ahmadi SE, et al. | Iran J Med Sci
Aim: To identify ophthalmic symptoms of COVID-19 patients and establish an association between these symptoms and SARS-CoV-2 infection.
|
|
|
1/13/22
|
Williams BE, Kondo KK, Ayers CK, et al. | Health Equity
Aim: To identify interventions that have effectively reduced disparities in health outcomes in infectious disease outbreaks or natural disasters in the United States and understand whether such interventions could be applied to reduce health disparities in the current COVID-19 pandemic. VA ESP
|
|
|
1/12/22
|
Dzinamarira T, Murewanhema G, Mhango M, et al. | Int J Environ Res Public Health
Aim: To map and analayse the available global evidence on the prevalence of SARS-CoV-2 infections among healthcare workers.
|
|
|
1/12/22
|
Jdiaa SS, Mansour R, El Alayli A, et al. | J Nephrol
Aim: To summarize the effect of CKD on different outcomes among patients with COVID–19. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/12/22
|
Zuin M, Roncon L, Zuliani G. | J Cardiovasc Med
Aim: To compare the echocardiographic systolic pulmonary arterial pressure (sPAP) difference between COVID-19 survivors (S) and nonsurvivors (NS).
|
|
|
1/12/22
|
Elharake JA, Akbar F, Malik AA, et al. | Child Psychiatry Hum Dev
Aim: To learn about the impact of the COVID-19 pandemic on the mental health of children, adolescents, and college students.
|
|
|
1/12/22
|
Niquini RP, Corrêa da Mota J, Bastos LS, et al. | Sci Rep
Aim: To assess HCV infection rates in haemodialysis patients in Brazil.
|
|
|
1/12/22
|
Liyanage S, Saqib K, Khan AF, et al. | Int J Environ Res Public Health
Aim: To estimate the global prevalence of anxiety among university students during the COVID-19 pandemic.
|
|
|
1/12/22
|
Reis S, Popp M, Schmid B, et al. | J Clin Med
Aim: To determine the safety and efficacy of intensified anticoagulation with intermediate or therapeutic doses compared to standard-dose thromboprophylaxis in hospitalised patients with COVID-19. RECENTLY UPDATED
CANDIDATE THERAPEUTICS
|
|
|
1/11/22
|
Salman MA, Mallah SI, Khalid W, et al. | Int J Gen Med
Aim: To investigate the clinical characteristics of patients whose cerebrospinal fluid (CSF) tested positive for SARS-CoV-2.
|
|
|
1/11/22
|
Pranata R, Huang I, Lim MA, et al. | Front Med
Aim: To assess whether elevated De Ritis ratio is associated with poor prognosis in patients with coronavirus 2019 (COVID-19). RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Xavier-Santos D, Padilha M, Fabiano GA, et al. | Trends Food Sci Technol
Aim: To provide insights and perspectives for the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention/treatment and/or modulation of the microbiota in COVID-19 patients.
|
|
|
1/11/22
|
Janmohamed K, Walter N, Nyhan K, et al. | J Health Commun
Aim: To evaluate the relative impact of interventions designed to mitigate COVID-19-related misinformation.
|
|
|
1/11/22
|
Shrestha DB, Sedhai YR, Budhathoki P, et al. | Ann Med Surg
Aim: To assess the value and significance of spontaneous pulmonary barotrauma such as pneumothorax, pneumomediastinum, and subcutaneous emphysema in patients with COVID-19. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Schlage S, Lehrnbecher T, Berner R, et al. | Eur J Pediatr
Aim: To update the available information on SARS-CoV-2 infections in pediatric cancer patients.
|
|
|
1/11/22
|
Hernández-Vásquez A, Chavez-Ecos F, Barrenechea-Pulache A, et al. | PeerJ
Aim: To estimate the seroprevalence and lethality attributable to SARS-CoV-2 in the indigenous population of LAC. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Ogungbe O, Kumbe B, Fadodun O, et al. | Int J Cardiol Heart Vasc
Aim: To quantify the association between biomarkers of myocardial injury (troponin), myocardial stretch (NT-proBNP, Gal-3), coagulation (D-Dimer), inflammation (CRP, IL-6) and severe COVID-19 or death in hospitalized patients. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Marchand G, Patil AS, Masoud AT, et al. | AJOB Glob Rep
Aim: To review the evidence on the maternal and neonatal outcomes in pregnant women infected with the Coronavirus Disease 2019 (COVID-19).
|
|
|
1/11/22
|
Hada M, Mosholder AD, Leishear K, et al. | Neurol Sci
Aim: To examine the available data on U.S. therapies approved to treat MS and the risk of SARS-CoV-2 infection or severe COVID-19 outcomes.
|
|
|
1/11/22
|
Zeynali Bujani M, Behnampour M, Rahimi N, et al. | Malays J Med Sci
Aim: To review the evidence on the effect of influenza vaccination on the prevention of COVID-19 and its consequences in patients.
|
|
|
1/11/22
|
Carbone EA, de Filippis R, Roberti R, et al. | Front Psychol
Aim: To systematically review the psychological consequences of the COVID-19 lockdown in caregivers of patients with cognitive impairment and dementia and the impact on the health of their patients.
|
|
|
1/11/22
|
Mahmoudi E, Mollazadeh R, Mansouri P, et al. | Clin Cardiol
Aim: To evaluate electrocardiogram (ECG) markers of repolarization heterogeneity in patients hospitalized with COVID-19. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Chiodini I, Gatti D, Soranna D, et al. | Front Public Health
Aim: To investigate whether vitamin D status is associated with the COVID-19 severity, defined as ARDS requiring admission to intensive care unit (ICU) or mortality (primary endpoints) and with the susceptibility to SARS-CoV-2 and COVID-19-related hospitalization (secondary endpoints).
|
|
|
1/10/22
|
Strasser MA, Sumner PJ, Meyer D | J Affect Disord
Aim: To synthesise the research findings on the relationship between COVID-19 news and distress in young people.
|
|
|
1/10/22
|
Bakr AM, El-Sakka AI, et al. | Int J Impot Res
Aim: To review the evidence on the change in erectile function among patients and health care providers during the COVID-19 pandemic. RECENTLY UPDATED
|
|
|
1/10/22
|
Omar M, Youssef MR, Trinh LN, et al. | Birth
Aim: To evaluate variations in clinical presentation, laboratory findings, and maternal/neonatal outcomes in COVID-19 patients who delivered vaginally versus via cesarean.
|
|
|
1/10/22
|
Saengsiwaritt W, Jittikoon J, Chaikledkaew U, et al. | Rev Med Virol
Aim: To clarify associations of genetic variants in those genes with COVID-19 susceptibility and severity.
|
|
|
1/10/22
|
Aria H, Mahmoodi F, Ghaheh HS, et al. | Anal Biochem
Aim: To review research studies that have applied nanobodies to diagnose or neutralize SARS-CoV-2.
|
|
|
1/10/22
|
Vera San Juan N, Clark SE, Camilleri M, et al. | BMJ Open
Aim: To provide a detailed understanding of redeployment and training during the first year of the COVID-19 pandemic by capturing and considering the merit of the strategies enlisted and the experiences and needs of redeployed healthcare workers (HCWs).
|
|
|
1/7/22
|
Yu R, Zhang S, Zhao D, et al. | Expert Rev Mol Med
Aim: To compare the outcomes of COVID-19 patients treated with Integrated Chinese with Western Medicine versus Western Medicine alone.
CANDIDATE THERAPEUTICS
|
|
|
1/7/22
|
Alzahrani F, Alshahrani NZ, Sabah AA, et al. | Psych J
Aim: To review the prevalence and associated factors of common mental disorders (i.e., depression, anxiety, and stress) related to the pandemic among the Saudi general population.
MENTAL HEALTH
|
|
|
1/6/22
|
Bielski K, Makowska K, Makowski A, et al. | Cardiol J
Aim: To update the information about the impact of coronavirus disease 2019 (COVID-19) pandemic on outcomes of in-hospital cardiac arrest (IHCA).
|
|
|
1/6/22
|
Amirian A, Pakzad R, Hasanpour V, et al. | J Matern Fetal Neonatal Med
Aim: To investigate neonatal outcomes among pregnant women with COVID-19. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/6/22
|
MarraMS ARM, Kobayashi T, Suzuki H, et al. | J Infect
Aim: To review the evidence on the impact of COVID-19 vaccination on neutralizing antibodies and the short-term effectiveness of COVID-19 vaccines among immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 infection. RECENTLY UPDATED
INFECTION CONTROL
|
|
|
1/5/22
|
Thatiparthi A, Liu J, Martin A, et al. | J Clin Aesthet Dermatol
Aim: To review the evidence on adverse facial reactions associated with use of face masks during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
1/5/22
|
Molaee H, Emadi SN, M'Imunya JMN, et al. | Dermatol Ther
Aim: To investigate chilblain-like lesions in children during the COVID-19 pandemic, any predisposition, location, clinical course, and prognosis.
CLINICAL CHARACTERISTICS
|
|
|
1/5/22
|
Matar RH, Than CA, Nakanishi H, et al. | Blood Coag Fibrinolysis
Aim: To investigate the outcomes of patients with thromboembolic events following the AstraZeneca vaccine (ChAdOx1 nCoV-19, AZD1222).
INFECTION CONTROL
|
|
|
1/5/22
|
Cui Y, Zhao B, Li T, et al. | Brain Res Bull
Aim: To evaluate the association between the risk of ischemic stroke and COVID-19. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/4/22
|
Azeez TA, Lakoh S, Adeleke AA, et al. | Indian J Pharmacol
Aim: To provide evidence for the use of ivermectin to prevent COVID-19 among hospital workers in low-resource countries.
INFECTION CONTROL
|
|
|
1/4/22
|
Bhattacharyya A, Sarma P, Kaur H, et al. | Indian J Pharmacol
Aim: To review the evidence on the demographic and clinical profile, risk factors, impact of different interventions, and outcomes among C-ROCM cases.
CLINICAL CHARACTERISTICS
|
|
|
1/4/22
|
Sholzberg M, da Costa BR, Tang GH, et al. | Res Pract Thromb Haemost
Aim: To determine the effects of therapeutic heparin in hospitalized patients with COVID?19.
CANDIDATE THERAPEUTICS
|
|
|
1/4/22
|
Kow CS, Ramachandram DS, Hasan SS | J Med Virol
Aim: To summarize the overall effectiveness of mRNA-1273 vaccine against COVID-19 caused by delta variant.
INFECTION CONTROL
|
|
|
1/3/22
|
Ceban F, Ling S, Lui LMW, et al. | Brain Behav Immun
Aim: To quantify the proportion of individuals experiencing fatigue and cognitive impairment 12 or more weeks following COVID-19 diagnosis, and to characterize the inflammatory correlates and functional consequences of post-COVID-19 syndrome. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/3/22
|
Changal K, Veria S, Mack S, et al. | BMC Cardiovasc Disord
Aim: To review the evidence on the effect of myocardial injury on the clinical outcome of patients hospitalized with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/3/22
|
Kheyrandish S, Rastgar A, Arab-Zozani M, et al. | Front Med
Aim: To review the evidence on portal vein thrombosis development through COVID-19 infection or vaccination.
CLINICAL CHARACTERISTICS
|
|
|
1/3/22
|
Jahan N, Brahma A, Kumar MS, et al. | Int J Infect Dis
Aim: To summarize the seroprevalence of SARS-CoV-2 and quantitatively estimate the pooled seroprevalence of SARS-CoV-2 among the Indian population. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/3/22
|
Kow CS, Lee LH, Ramachandram DS, et al. | Immun Inflamm Dis
Aim: To investigate the effect of colchicine in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/31/21
|
Ge J, Ma Y, Wu Z, et al. | Medicine
Aim: To better inform efforts to treat and control the current outbreak with effective anticoagulant treatment strategies for coronavirus disease 2019 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/31/21
|
Al-Ali D, Elshafeey A, Mushannen M, et al. | J Cell Mol Med
Aim: To examine all the reported cardiovascular and haematological events post COVID-19 vaccination in published literature and to suggest possible mechanisms to explain these rare phenomena.
INFECTION CONTROL
|
|
|
12/31/21
|
Jaiswal V, Alquraish D, Sarfraz Z, et al. | J Prim Care Community Health
Aim: To provide thorough analyses of associations between COVID-19 and neurological outcomes for patients with PD.
CLINICAL CHARACTERISTICS
|
|
|
12/30/21
|
Chiu L, Lo C, Shen M, et al. | PLoS One
Aim: To report on the state of the current literature on the use of colchicine in COVID-19 and to investigate the reported clinical outcomes in COVID-19 patients by colchicine usage. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/30/21
|
Chen Y, Li L, Zhang Q, et al. | Medicine
Aim: To evaluate the epidemiology, methodological quality, and reporting characteristics of published SRs/meta-analyses related to COVID-19.
INFECTION CONTROL
|
|
|
12/30/21
|
Fresna RH, Atikah SN, Salsabila MM, et al. | J Health Policy Management
Aim: To review the evidence on gender issues in mental health responses by health workers.
INFECTION CONTROL
|
|
|
12/30/21
|
Wang F, Boros S | Baltic Journal of Health and Physical Activity
Aim: To review the evidence of mental and physical health consequences during COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
12/30/21
|
Baez-Ferrer N, Bompart-Cairos A, Lopez-Rial D, et al. | Cardiomyopathy and Heart Failure
Aim: To analyze the mortality of patients with ARDS due to SARS-CoV-2 who required ECMO.
CANDIDATE THERAPEUTICS
|
|
|
12/30/21
|
Sarwoko TA, Bahri AS | J Matern Child Health
Aim: To determine the effect of the COVID-19 pandemic lockdown on the physical activity and sleeping habits of children and adolescents.
INFECTION CONTROL
|
|
|
12/30/21
|
Ahmed S, Mansoor M, Shaikh MS, et al. | Indian J Crit Care Med
Aim: To evaluate the global scientific literature on the utility of plasma presepsin (PSP) as a prognostic biomarker in a homogeneous group of coronavirus disease 2019 (COVID-19) positive cases.
INFECTION CONTROL
|
|
|
12/30/21
|
Ali NA, Khoja A, Kazim F | Turk Psikiyatri Derg
Aim: To highlight the role of telemental health services during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
12/29/21
|
Dragioti E, Li H, Tsitsas G, et al. | J Med Virol
Aim: To quantify the mental health burden of COVID-19 pandemic.
MENTAL HEALTH
|
|
|
12/29/21
|
Khandker SS, Godman B, Jawad MI, et al. | Vaccines
Aim: To review the current vaccine candidates, focusing on their development strategy, adverse events, and effectiveness based on the published findings.
INFECTION CONTROL
|
|
|
12/29/21
|
Jang W, Kim B, Kim ES, et al. | J Korean Med Sci
Aim: To investigate how effectively national and international guidelines provide recommendations for infection control issues in hospitals.
INFECTION CONTROL
|
|
|
12/29/21
|
Oliveira MR, Sudati IP, Konzen VM, et al. | Exp Gerontol
Aim: To evaluate the available evidence related to the level of physical activity (PA) of elderly people during the COVID-19 pandemic. UPDATED
|
|
|
12/29/21
|
Akyol M, Çevik E, Ucku D, et al. | Tuberk Toraks
Aim: To analyze the antibody responses after a full series of mRNA-based SARS-CoV-2 vaccination in kidney transplantation and dialysis patients.
INFECTION CONTROL
|
|
|
12/29/21
|
Guan Z, Chen C, Li Y, et al. | Front Public Health
Aim: To evaluate the impact of coinfection with SARS-CoV-2 and influenza on mortality, critical outcomes involving shock, being admitted to ICU or requiring ventilatory support, as well as relevant clinical symptoms and laboratory index compared with mono-infections of SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
12/29/21
|
Lee YK, Huang YH | Vaccines
Aim: To help clinicians recognize the possible manifestations and systemic pathogenesis, especially those related to the eye, after receiving COVID-19 vaccination.
INFECTION CONTROL
|
|
|
12/29/21
|
Zhu J, Racine N, Xie EB, et al. | Front Psychiatry
Aim: To examine the global prevalence of clinically significant depression and anxiety among post-secondary students during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
12/29/21
|
Ma KS, Lee CC, Liu KJ, et al. | Pathogens
Aim: To evaluate strategies for augmentation of host immunity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection.
CANDIDATE THERAPEUTICS
|
|
|
12/29/21
|
Dashti S, Bolghanabadi N, Ghavami V, et al. | J Sex Marital Ther
Aim: To review the evidence on the impact of the COVID-19 pandemic on female sexual function.
CLINICAL CHARACTERISTICS
|
|
|
12/29/21
|
Viner R, Waddington C, Mytton O, et al. | J Infect
Aim: To review the evidence on the extent that children and young people (CYP) under 20 years of age transmit SARS-CoV-2 to other CYP and to adults in household and child-specific (e.g. educational) settings. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/29/21
|
Tentolouris N, Samakidou G, Eleftheriadou I, et al. | Diabetes Metab Res Rev
Aim: To investigate the effect of vitamin D supplementation on mortality and admission to intensive care unit (ICU) of COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
12/29/21
|
Racine N, Eirich R, Cooke J, et al. | Infant Ment Health J
Aim: To identify the prevalence of depression and anxiety in parents of young children ( UPDATED
MENTAL HEALTH
|
|
|
12/29/21
|
Amanollahi A, Sotoodeh Ghorbani S, Basir Ghafouri H, et al. | Med J Islam Repub Iran
Aim: To systematically assess and estimate the clinical, laboratory, and imaging features related to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Makoah NA, Tipih T, Litabe MM, et al. | Future Virol
Aim: To investigate the utility of serological tests for the diagnosis of COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT-PCR.
DIAGNOSTICS
|
|
|
12/27/21
|
Jennings G, Monaghan A, Xue F, et al. | J Clin Med
Aim: To compare the two phases of long COVID, namely ongoing symptomatic COVID-19 and post-COVID-19 syndrome with respect to symptomatology, abnormal functioning, psychological burden, and quality of life. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Sessa F, Salerno M, Esposito M, et al. | J Clin Med
Aim: To clarify the major aspects of fatal adverse effects related to COVID-19 vaccines.
INFECTION CONTROL
|
|
|
12/27/21
|
Cuevas-Gonzalez MV, Espinosa-Cristóbal LF, Donohue-Cornejo A, et al. | Medicine
Aim: To identify the main signs and symptoms of COVID-19 in the oral cavity. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Zein AFMZ, Raffaello WM | Prim Care Diabetes
Aim: To synthesize the latest evidence on the effect of dipeptidyl peptidase-4 (DPP-IV) inhibitor in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/27/21
|
Pang KW, Tham SL, Ng LS | Life
Aim: To determine the pooled sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-) and diagnostic odds ratio (DOR) of using GD as a triage symptom prior to RT-PCR.
DIAGNOSTICS
|
|
|
12/27/21
|
Moreno-Sánchez E, Castillo-Viera E, Vélez-Moreno E, et al. | Medicina
Aim: To analyse the factors that affect the probability of the paediatric asthma population suffering from COVID-19 or SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Stoicescu ER, Ciuca IM, Iacob R, et al. | Diagnostics
Aim: To assess the evidence on the utility of lung ultrasound (LUS) in neonates diagnosed with COVID-19.
DIAGNOSTICS
|
|
|
12/27/21
|
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G | Cells
Aim: To analyze the current data regarding the new-onset systemic and rheumatic autoimmune diseases in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Menezes RG, Rizwan T, Saad Ali S, et al. | Leg Med
Aim: To identify studies reporting gross, histological, microscopic, and immunohistochemical findings on postmortem examination of COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Lieneck C, Bosworth M, Weaver E, et al. | Medicina
Aim: To investigate underlying themes (constructs) surrounding influences upon the U.S. population’s mental health distress as experienced during the COVID-19 pandemic to date.
MENTAL HEALTH
|
|
|
12/27/21
|
Khoshrounejad F, Hamednia M, Mehrjerd A, et al. | Front Public Health
Aim: To explore more specific properties of telehealth-based services, which were developed to support patients suspected of or afflicted with COVID-19 and healthcare providers.
INFECTION CONTROL
|
|
|
12/27/21
|
Golpour M, Mousavi T, Alimohammadi M, et al. | Int J Immunopathl Pharmacol
Aim: To evaluate the efficacy of Colchicine in the treatment of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/27/21
|
Kwak SG, Choo YJ, Chang MC | Complement Ther Med
Aim: To investigate the therapeutic effect of high-dose intravenous vitamin C (HDIVC) in patients with coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
12/27/21
|
Huerta-González S, Selva-Medrano D, López-Espuela F, et al. | Int J Environ Res Public Health
Aim: To analyze and synthesize qualitative studies that investigate the perceptions of nurses about the psychological impacts of treating hospitalized people with COVID-19 on the front line.
MENTAL HEALTH
|
|
|
12/24/21
|
Chen H, Yang G, Long Y, et al. | Evid Based Complement Alternat Med
Aim: To determine the role of lymphocyte and platelet counts as well as interleukin-6 levels as predictors of death in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
Rico-Martin S, Calderon-Garcia JF, Basilio-Fernandez B, et al. | J Cardiovasc Dev Dis
Aim: To investigate the relationship between metabolic syndrome (MetS) and its components with SARS and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the COVID-19 variant of concern dubbed Omicron. UPDATED
|
|
|
12/24/21
|
Bradley SA, Banach M, Alvarado N, et al. | J Diabetes
Aim: To determine the prevalence of diabetes in hospitalized COVID-19 patients and investigate the association of diabetes severe COVID-19, rate of acute respiratory distress syndrome (ARDS), mortality, and need for mechanical ventilation.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
Cai X, Wu G, Zhang J, et al. | Front Med
Aim: To analyse the risk factors for AKI in adult patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
McIntyre KM, Favre NM, Kuo CC, et al. | Cureus
Aim: To identify novel coronavirus disease 2019 (COVID-19) patients with a diagnosis of sudden sensorineural hearing loss (SSNHL) with an aim to describe possible mechanisms.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
Tomerak S, Khan S, Almasri M, et al. | Scand J Immunol
Aim: To compile clinical data of COVID-19 patients who developed thrombotic complications to investigate the possible role of hyperinflammation in inducing hypercoagulation.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
Wang J, Tong Y, Li D, et al. | Front Immunol
Aim: To analyze the difference of adverse events (AEs) rate and virus geometric mean titer (GMT) values between young and older people.
INFECTION CONTROL
|
|
|
12/23/21
|
Izcovich A, Peiris S, Ragusa M, et al. | J Clin Epidemiol
Aim: To summarize the best available evidence on ivermectin for prevention and treatment of COVID-19 patients and explore potential explanations for heterogeneity in RCTs results with focus on studies methodological limitations.
CANDIDATE THERAPEUTICS
|
|
|
12/23/21
|
Katsanos A, Palaiodimou L, Zand R, et al | Stroke
Aim: To evaluate the impact of COVID-19 pandemic on stroke epidemiology and care across the world. UPDATED
|
|
|
12/23/21
|
Szarpak L, Borkowska M, Peacock FW, et al. | Cardiol J
Aim: To review the evidence from interventional outcome studies in patients with in-hospital cardiac arrest before and during the coronavirus disease 2019 (COVID-19) pandemic period.
CLINICAL CHARACTERISTICS
|
|
|
12/23/21
|
Bastos SNMAN, Barbosa BLF, Cruz LGB, et al. | Rev Bras Ginecol Obstet
Aim: To analyze the clinical and obstetric aspects of pregnant women with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/23/21
|
Agarwal N, Mishra S, Ayub A | J Family Med Prim Care
Aim: To find out the impact on the discharge status from hospital of the patients receiving convalescent plasma therapy. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/23/21
|
Ebrahimi Chaharom F, Pourafkari L, Ebrahimi Chaharom AA, et al. | Pulm Pharmacol Ther
Aim: To evaluate the impact of corticosteroids on the mortality rate, HLOS, ICU admission, intubation, and mechanical ventilation in Covid-19 patients with severe pneumonia.
CANDIDATE THERAPEUTICS
|
|
|
12/23/21
|
Mehrdad R, Zahra K, Mansouritorghabeh H | Clin Appl Thromb Hemost
Aim: To determine the levels of fibrinogen, D-dimer and FDP in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/23/21
|
Wang Y, Liu Y | Prev Med Rep
Aim: To summarize multilevel determinants of COVID-19 vaccination intention in the US to inform future intervention opportunities.
INFECTION CONTROL
|
|
|
12/23/21
|
Otunla A, Rees K, Dennison P, et al. | BMJ Evid Based Med
Aim: To determine if and to what degree asthma may predispose to worse COVID-19 outcomes in order to inform treatment and prevention decisions, including shielding and vaccine prioritisation.
CLINICAL CHARACTERISTICS
|
|
|
12/23/21
|
Chiem C, Alghamdi K, Nguyen T, et al. | Transfus Med Hemother
Aim: To review the evidence on the impact of the COVID-19 pandemic on blood transfusion services.
INFECTION CONTROL
|
|
|
12/22/21
|
Agrawal S, Goel AD, Gupta N, et al. | Heart Lung
Aim: To assess the diagnostic yield of BAL for detection of SARS-CoV-2 in cases of non-diagnostic upper respiratory tract samples.
DIAGNOSTICS
|
|
|
12/22/21
|
Hussain N, Agarwala P, Iqbal K, et al. | J Med Virol
Aim: To compile and illustrate the clinical characteristics, physical examination findings, outcomes, and possible pathology behind acute TE occurring in COVID-19 recovered patients.
CLINICAL CHARACTERISTICS
|
|
|
12/22/21
|
Guo J, Qin Z, Lau NC, et al. | Am J Chin Med
Aim: To evaluate the efficacy and safety of Chinese medicine (CM) against COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/22/21
|
Koupaei M, Naimi A, Moafi N, et al. | Front Med
Aim: To evaluate the various aspects such as symptoms, diagnosis, treatment, and mortality rate.
CLINICAL CHARACTERISTICS
|
|
|
12/22/21
|
Alvarenga MOP, Veloso SRM, Bezerra ALCA, et al. | J Photochem Photobiol
Aim: To analyze the evidence from trials performed in healthcare facilities that assessed UV-C disinfection's ability to reduce manual cleaning failures enhancing the logarithmic reduction of nosocomial pathogens. colonized on surfaces. UPDATED
INFECTION CONTROL
|
|
|
12/22/21
|
Vidya G, Kalpana M, Roja K, et al. | Maedica
Aim: To examine the evidence on the clinical presentation of COVID-19 in children.
CLINICAL CHARACTERISTICS
|
|
|
12/22/21
|
Jafari M, Dastgheib SA, Ferdosian F, et al. | Hematol Transfus Cell Ther
Aim: To evaluate the proportion of hematological cancer patients with the SARS-CoV-2 infection during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
12/22/21
|
de Sire A, Andrenelli E, Negrini F, et al. | Eur J Phys Rehabil Med
Aim: To investigate the literature on rehabilitation services for COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/21
|
Mukherjee TI, Khan AG, Dasgupta A, et al. | Reprod Health
Aim: To systematically review empirical evidence of the indirect impacts of respiratory epidemics on SRH.
|
|
|
12/21/21
|
Sung K, Chang T, Wang Y, et al. | J Chin Med Assoc
Aim: To evaluate the efficacy and safety of SARS-CoV-2 vaccination in IBD patients. UPDATED
INFECTION CONTROL
|
|
|
12/20/21
|
Fazlollahi A, Zahmatyar M, Noori M, et al. | Rev Med Virol
Aim: To identify the clinical profile, investigations, and management of reported cardiac complications post-mRNA COVID-19 vaccines.
INFECTION CONTROL
|
|
|
12/20/21
|
Jacobs JW, Booth GS | Am J Clin Pathol
Aim: To summarize the epidemiologic, clinical, and laboratory characteristics of autoimmune hemolytic anemia (AIHA) secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination.
CLINICAL CHARACTERISTICS
|
|
|
12/20/21
|
Stainer A, Amati F, Suigo G, et al. | Semin Respir Crit Care Med
Aim: To describe clinical picture, disease severity, proposed treatment regimen, and response to vaccination in patients with different types and severity of immunosuppression.
CLINICAL CHARACTERISTICS
|
|
|
12/20/21
|
Koçak C | Iran J Public Health
Aim: To review the evidence on the importance of isolation and contact tracing, and what kinds of practices exist in different countries.
INFECTION CONTROL
|
|
|
12/20/21
|
Shafiq A, Salameh MA, Laswi I, et al. | J Clin Pharmacol
Aim: To identify reports of post-vaccination adverse neurological events.
INFECTION CONTROL
|
|
|
12/20/21
|
Deng D, Liang A, Chui JN, et al. | Nephrology
Aim: To evaluate the effect of the COVID-19 pandemic on access to healthcare for patients with CKD. UPDATED
|
|
|
12/20/21
|
AlAmodi AA, Al-Kattan K, Shareef MA | PLoS One
Aim: To form a preliminary and contemporary understanding of the general public knowledge, attitude, and behaviors towards the COVID-19 pandemic globally.
INFECTION CONTROL
|
|
|
12/20/21
|
Romero Starke K, Reissig D, Petereit-Haack G, et al. | BMJ Glob Health
Aim: To quantify the isolated effect of age on hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/20/21
|
Carbone L, Di Girolamo R, Mappa I, et al. | Eur J Obstet Gynecol Reprod Biol
Aim: To evaluate the evidence from the literature regarding the acceptance rate of the SARS-CoV-2 vaccine in pregnant and breastfeeding women.
INFECTION CONTROL
|
|
|
12/17/21
|
Gagelmann N, Passamonti F, Wolschke C, et al. | Haematologica
Aim: To systematically analyse the outcomes of patients with haematological malignancies who received vaccination and to identify specific groups with differences in outcomes.
CLINICAL CHARACTERISTICS
|
|
|
12/17/21
|
Bilotta C, Perrone G, Adelfio V, et al. | Front Immunol
Aim: To analyze published cases of thrombosis after COVID-19 vaccinations to identify patients’ features, potential pathophysiological mechanisms, timing of appearance of the adverse events, and other critical issues.
CLINICAL CHARACTERISTICS
|
|
|
12/17/21
|
| NSW Health COVID-19 Critical Intelligence Unit
UPDATED
|
|
|
12/17/21
|
Castillo-Perez M, Jerjes-Sanchez C, Castro-Varela A, et al. | Thromb J
Aim: To determine the therapeutic trends and outcomes in VTE COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/17/21
|
Omer AAA | J Educ Health Promot
Aim: To review the perspectives of general surgical practice during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
12/17/21
|
Arabpour E, Khoshdel S, Tabatabaie N, et al. | Front Med
Aim: To evaluate the safety and efficacy of stem cells in treating patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/17/21
|
Crichton ML, Goeminne PC, Tuand K, et al. | Eur Respir Rev
Aim: To show the impact of different COVID-19 therapeutics on mortality in hospitalised patients.
CANDIDATE THERAPEUTICS
|
|
|
12/17/21
|
Dhillon RA, Qamar MA, Gilani JA, et al. | Ann Med Surg
Aim: To assess the determinants and disease spectrum of COVID-19 reinfection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/16/21
|
Bertini P, Guarracino F, Falcone M, et al. | J Cardiothorac Vasc Anesth
Aim: To summarize evidence from all available studies to assess the mortality of patients with COVID-19 treated with VV ECMO. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/16/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the efficacy of face masks in helping to prevent the spread of COVID-19. UPDATED
|
|
|
12/16/21
|
Impact of COVID-19 pandemic on haemorrhagic stroke admissions: a systematic review and meta-analysis
 You Y, Niu Y, Sun F, et al. | BMJ Open
Aim: To evaluate the impact of the COVID-19 pandemic on stroke hospitalisations, especially haemorrhagic stroke.
CLINICAL CHARACTERISTICS
|
|
|
12/16/21
|
Mao YJ, Wang WW, Ma J, et al. | Chin Med J
Aim: To assess the incidence of SARS-CoV-2 reinfection and the protection effect of previous infection against reinfection.
CLINICAL CHARACTERISTICS
|
|
|
12/16/21
|
Abid MA, Abid MB | Hematol Oncol
Aim: To review the evidence on SARS-CoV-2 vaccine response in CAR T-cell therapy recipients.
INFECTION CONTROL
|
|
|
12/16/21
|
Raji H, Arjmand B, Rahim F | Adv Exp Med Biol
Aim: To evaluate the probable effect of the PBM therapy on the lung inflammation or ARDS and accelerate the regeneration of the damaged tissue.
CANDIDATE THERAPEUTICS
|
|
|
12/16/21
|
Waqar U, Ahmed S, Gardezi SMHA, et al. | Clin Appl Thromb Hemost
Aim: To explore the pathophysiology, epidemiology, diagnosis, management, and prognosis of TTS. UPDATED
INFECTION CONTROL
|
|
|
12/16/21
|
Rungjirajittranon T, Owattanapanich W, Leelakanok N, et al. | Clin Appl Thromb Hemost
Aim: To better understand the incidence of thrombosis, bleeding, and mortality rates among patients discharged after COVID-19 hospitalization.
CLINICAL CHARACTERISTICS
|
|
|
12/15/21
|
van Reekum EA, Rosic T, Sergeant A, et al. | J Med Case Rep
Aim: To synthesize neuropsychiatric outcomes of COVID-19 in people with preexisting psychiatric disorders.
CLINICAL CHARACTERISTICS
|
|
|
12/15/21
|
Ma Q, Liu J, Liu Q, et al. | JAMA Netw Open
Aim: To evaluate the percentage of asymptomatic infections among individuals undergoing testing (tested population) and those with confirmed COVID-19 (confirmed population).
CLINICAL CHARACTERISTICS
|
|
|
12/15/21
|
Dadras O, Afsahi AM, Pashaei Z, et al. | Immun Inflamm Dis
Aim: To systematically review the association between SARS-CoV-2 viral load and COVID-19 severity.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Khan S, Hasan SS, Bond SE, et al. | Expert Rev Anti Infect Ther
Aim: To review the evidence on the consumption of antimicrobials by patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/14/21
|
Abu-Amara J, Szpecht D, Al-Saad SR, et al. | Arch Med Sci
Aim: To assess the relationship of COVID-19 with the early gestational trimesters of pregnancy.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Hosseini SF, Behnam-Roudsari S, Alavinia G, et al. | J Res Med Sci
Aim: To determine whether clinicians used these scoring systems while assessing COVID-19 patients and the role of relevant biomarkers in disease severity and outcome.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Zuin M, Engelen MM, Barco S, et al. | Thromb Res
Aim: To estimate the incidence of VTE after hospital discharge among COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Naderi N, Rahimzadeh M | Virology
Aim: To determine whether KL-6 could be used as a prognostic factor for severe COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Szarpak L, Filipiak KJ, Skwarek A, et al. | Cardiol J
Aim: To determine the impact of AF/atrial flutter (AFL) on mortality, as well as individual complications in patients hospitalized with the coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Dorri S, Sari F, Seyedhasani SN, et al. | Front Surg
Aim: To outline a guideline for preoperative screening before cancer surgeries and protecting health care workers during the pandemic.
INFECTION CONTROL
|
|
|
12/14/21
|
Zhang SX, Chen J | Eur J Psychotraumatol
Aim: To summarize the prevalence of anxiety, depression, and insomnia in the general adult population and healthcare workers (HCWs) in several key regions worldwide during the first year of the COVID pandemic.
MENTAL HEALTH
|
|
|
12/14/21
|
Bahji A, Bach P, Danilewitz M, et al. | Psychiatr Res Clin Pract
Aim: To synthesize evidence for interventions to support self?isolation and mandated quarantine for COVID?19 among individuals with SPMIs.
MENTAL HEALTH
|
|
|
12/14/21
|
Ruksakulpiwat S, Zhou W, Phianhasin L, et al. | Chronic Illn
Aim: To identify the difficulties that caregivers of chronically ill patients experienced during the COVID-19 pandemic and to provide directions for future studies. UPDATED
MENTAL HEALTH
|
|
|
12/14/21
|
Chahley ER, Reel RM, Taylor S | SSM Qual Res Health
Aim: To synthesize qualitative literature exploring the lived experience of healthcare workers (HCWs) who cared for patients during the following infectious disease outbreaks (IDOs): the 2003 SARS epidemic, 2009 H1N1 pandemic, 2012 MERS outbreak, and 2014 EVD epidemic.
MENTAL HEALTH
|
|
|
12/13/21
|
Burns KEA, Laird M, Stevenson J, et al. | JAMA Netw Open
Aim: To appraise the quality of clinical practice guidelines (CPGs) using the National Academy of Medicine (NAM) criteria. UPDATED
|
|
|
12/13/21
|
Ebrahimzadeh A, Mohseni S, Narimani B, et al. | Crit Rev Food Sci Nutr
Aim: To review the evidence on the association between vitamin D status and risk of COVID-19 in-hospital mortality among observational studies.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Pegollo L, Maggioni E, Gaeta M, et al. | Acta Biomed
Aim: To review the evidence on population DCT acceptance. UPDATED
INFECTION CONTROL
|
|
|
12/13/21
|
Wang Y, Yang J, Qiao F, et al. | Am J Infect Control
Aim: To systematically review the literature and conduct a meta-analysis of studies investigating the rate of HHC and the characteristics of HH during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
12/13/21
|
Ishak A, Al Rawashdeh MM, Esagian SM, et al. | J Clin Med
Aim: To assess the diagnostic performance of droplet digital PCR (ddPCR), also to evaluate its potential role in prognosis and management of COVID-19 patients.
DIAGNOSTICS
|
|
|
12/13/21
|
Damayanthi HDWT, Prabani KIP, Weerasekara I | Gerontol Geriatr Med
Aim: To identify various factors associated with mortality among older people infected with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Agolli A, Agolli O, Velazco DFS, et al. | Avicenna J Med
Aim: To understand the role of COVID-19 infection in causing pregnancy complications specifically fatal outcomes.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Kollias A, Kyriakoulis KG, Trontzas IP, et al. | J Clin Med
Aim: To assess the risk of in-hospital mortality in hospitalized patients with COVID-19 receiving high (intermediate or therapeutic) versus prophylactic doses of thromboprophylaxis. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/13/21
|
Alenezi FK, Almeshari MA, Mahida R, et al. | Ren Fail
Aim: To assess the incidence and risk factors of AKI, need for kidney replacement therapy (KRT), and mortality rate among COVID-19 patients with and without ARDS from the first wave of COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of monoclonal antibodies for the treatment of COVID-19.
|
|
|
12/13/21
|
Orilisi G, Mascitti M, Togni L, et al. | Int J Environ Res Public Health
Aim: To investigate the frequency of oral manifestations in COVID-19 hospitalized patients.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Chen MY, Xiao FP, Kuai L, et al. | Am J Emerg Med
Aim: To provide a comprehensive description of the impact of AF on the prognosis of patients with COVID-19 pneumonia.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Sharma D, Bhaskar SMM | APMIS
Aim: To determine a pooled prevalence estimate of PHICs in paediatric and adolescent hospitalised patients admitted for treatment due to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Dissanayake HA, de Silva NL, Sumanatilleke M, et al. | J Clin Endocrinol Metab
Aim: To determine the association between vitamin D deficiency/insufficiency and susceptibility to COVID-19, its severity, mortality and role of vitamin D in its treatment.
CANDIDATE THERAPEUTICS
|
|
|
12/13/21
|
Abrokwa SK, Müller SA, Méndez-Brito A, et al. | PLoS One
Aim: To review the evidence on the extent and characteristics of reinfections and re-positive rates of SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the safety and efficacy of COVID-19 vaccination in renal dialysis patients.
|
|
|
12/13/21
|
Kokkotis G, Kitsou K, Xynogalas I, et al. | Aliment Pharmacol Ther
Aim: To investigate the impact of anti-TNF treatments on the clinical outcomes of COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
12/13/21
|
Pérez-Peralta L, Sauceda-Valenzuela AL, La Parra DR, et al. | Oman J Ophthamol
Aim: To identify preventive measures that will aid in reducing the risk of infection during standard appointments between patients and visual health professionals.
INFECTION CONTROL
|
|
|
12/13/21
|
Elisabeth AL, Karlen SB, Magkos F | Aging Dis
Aim: To conduct a thorough analysis of the current literature on the effects of the COVID-19-related lockdowns on diet and physical activity habits in older individuals. UPDATED
|
|
|
12/13/21
|
Bielski K, Szarpak A, Jaguszewski MJ, et al. | J Clin Med
Aim: To evaluate the influence of COVID-19 on OHCA survival outcomes.
|
|
|
12/13/21
|
Bursky M, Kosuri M, Walsh Carson K, et al. | Psychol Rep
Aim: To review the evidence on the benefits of various types of meditation and MBIs for inmates and individuals in lockdown or quarantine.
MENTAL HEALTH
|
|
|
12/9/21
|
Matta A, Kunadharaju R, Osman M, et al. | Cureus
Aim: To assess the demographics, risk factors, clinical presentation, investigational findings including electrocardiogram (EKG), echocardiogram (Echo) and cardiac magnetic resonance imaging (MRI), hospital length of stay (LOS), and outcomes in patients who developed myocarditis following administration of mRNA vaccine for COVID-19.
INFECTION CONTROL
|
|
|
12/9/21
|
Chen X, Huang Z, Wang J, et al. | BMJ Open
Aim: To estimate the rate of asymptomatic COVID-19 from published studies and compare this rate among different regions and patient groups.
CLINICAL CHARACTERISTICS
|
|
|
12/9/21
|
Tiwari S, Kc N, Thapa S, et al. | Middle East Fertil Soc J
Aim: To analyze the overall consequences of COVID-19 on semen parameters and male sex hormones. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/8/21
|
Li Y, Wei Z, Ma X, et al. | Curr Stem Cell Res
Aim: To assess the safety and efficacy of stem cell therapy for COVID-19 by providing references for subsequent clinical treatments and trials.
CANDIDATE THERAPEUTICS
|
|
|
12/8/21
|
Teoh SE, Masuda Y, Tan DJH, et al. | Ann Intensive Care
Aim: To evaluate the impact of the pandemic on the incidence and case fatality rate (CFR) of OHCA. UPDATED
|
|
|
12/8/21
|
Silva DFO, Cobucci RN, Lima SCVC, et al. | Medicine
Aim: To identify the prevalence of anxiety, depression, and stress among teachers during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
12/7/21
|
Al Maqbali M, Al Badi K, Al Sinani M, et al. | Biol Res Nurs
Aim: To identify the prevalence of the clinical symptoms of patient with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Sarkar S, Khanna P, Singh AK | Indian J Crit Care Med
Aim: To analyze the current evidence of the efficacy and safety of convalescent plasma therapy in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
12/7/21
|
Jackson WM, Price JC, Eisler L, et al. | J Neurosurg Anesthesiol
Aim: To assess the scope of diagnosis, treatment, and management of COVID-19 in pediatric patients.
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Jafari Y, Yin M, Lim C, et al. | Infect Prev Pract
Aim: To collate and assess evidence on the effectiveness of IPC interventions, excluding PPE, intended to reduce transmission of SARS-CoV-2 between patients, between patients and healthcare workers, and between healthcare workers within the hospital setting.
INFECTION CONTROL
|
|
|
12/7/21
|
Shenai MB, Rahme R, Noorchashm H | Cureus
Aim: To compare the protection of natural immunity in the COVID-recovered versus the efficacy of complete vaccination in the COVID-naive.
INFECTION CONTROL
|
|
|
12/7/21
|
Santos MO, Gonçalves LC, Silva PAN, et al. | J Pediatr
Aim: To describe the main symptoms of MIS-C and characterize its treatment and possible outcomes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Jeyalan V, Storrar J, Wu HHL, et al. | World J Transplant
Aim: To provide an overview of the current literature on the renal histopathological features and mechanistic insights described in association with coronavirus disease 2019 (COVID-19) infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Mahmud S, Mohsin M, Dewan MN, et al. | Research Square
Aim: To examine research findings related to depression, anxiety, stress, and insomnia during the COVID-19 pandemic
MENTAL HEALTH
|
|
|
12/7/21
|
Ma C, Tu D, Gu J, et al. | Front Cardiovasc Med
Aim: To explore the predictive value of elevated Mb for adverse outcomes of patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Sahebi A, Yousefi A, Abdi K, et al. | Front Psychiatry
Aim: To estimate the overall prevalence of PTSD among HCWs. UPDATED
MENTAL HEALTH
|
|
|
12/6/21
|
Ghahramani S, Lankarani KB, Yousefi M, et al. | Front Psychiatry
Aim: To present a comprehensive picture of the prevalence of burnout among healthcare workers during the COVID-19 pandemic. UPDATED
|
|
|
12/6/21
|
Ikeagwulonu RC, Ugwu NI, Ezeonu CT, et al. | West Afr J Med
Aim: To provide evidence that will guide clinical management by reviewing studies that assessed CRP concentration and COVID-19 severity/outcome.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
De-Miguel-Balsa E, Estevan-Ortega R, Sempere-Selva MT, et al. | Eur Rev Med Pharmacol Sci
Aim: To assess the effectiveness of colchicine, compared with standard of care, for reducing mortality, admission to intensive care, and use of mechanical ventilation.
CANDIDATE THERAPEUTICS
|
|
|
12/6/21
|
McDaniel CG, Commander SJ, DeLaura I, et al. | J Pediatr Hematol Oncol
Aim: To review the evidence on coagulation abnormalities and clinical complications in children With SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on fomites as a transmission route for COVID-19 infection.
|
|
|
12/6/21
|
Yunitri N, Chu H, Kang XL, et al. | Int J Nurs Stud
Aim: To examine the global prevalence and associated risk factors of PTSD in patients/survivors of COVID-19, health professionals, and the population at large. UPDATED
|
|
|
12/6/21
|
Ribaric NL, Vincent C, Jonitz G, et al. | Indoor Air
Aim: To identify hazards of viral dispersal and enable more precise targeting of infection prevention and control.
INFECTION CONTROL
|
|
|
12/6/21
|
Yadav DK, Adhikari VP, Ling Q, et al. | Front Med
Aim: To approximate the prognosis of LT recipients with COVID-19 on the standard maintenance IS.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
Patrucco F, Zeppegno P, Baricich A, et al. | Minerva Med
Aim: To review systematically emerging evidence about clinical and functional consequences of Covid-19 pneumonia months after hospital discharge.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on paediatric respiratory infections following lockdown and school reopening.
|
|
|
12/6/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on post-acute sequelae of COVID-19 infection.
|
|
|
12/6/21
|
Yu T, Wang H, Zheng S, et al. | Infect Drug Resist
Aim: To perform a comprehensive review and identify clinical cases with COVID-19 complicated by CVD to establish possible demographic, clinical, laboratory patterns, and prognostic features of these cases.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of Sotrovimab as a treatment for COVID-19.
|
|
|
12/6/21
|
Mirashrafi S, Moravejolahkami AR, Balouch Zehi Z, et al. | Clin Nutr ESPEN
Aim: To conduct a rapid review of probiotics with specific emphasis on their potential for early administration in patients at greater risk of SARS-CoV-2 infection. UPDATED
|
|
|
12/6/21
|
Pu R, Liu S, Ren X, et al. | J Virols Methods
Aim: To evaluate the diagnostic accuracy of RT-PCR and RT-LAMP and the potential effects of reference methods on diagnostic accuracy.
DIAGNOSTICS
|
|
|
12/3/21
|
Makara-Studzinska M, Zaluski M, Lickiewicz J | Psychiatria
Aim: To evaluate the mental health problems of COVID-19 survivors.
MENTAL HEALTH
|
|
|
12/3/21
|
Jaiswal V, Sarfraz Z, Sarfraz A, et al. | J Prim Care Community Health
Aim: To collate current evidence about demographics, symptomatology, diagnostic, and clinical outcomes of COVID-19 infected patients with myocarditis.
CLINICAL CHARACTERISTICS
|
|
|
12/3/21
|
Khan DSA, Hamid LR, Ali A, et al. | BMC Pregnancy Childbirth
Aim: To assess differences in risk factors, management, complications, and pregnancy and perinatal outcomes in symptomatic vs. asymptomatic pregnant women with confirmed SARS-CoV-2 infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/3/21
|
Teh JSK, Coussement J, Neoh ZCF, et al. | Blood Adv
Aim: To assess the immunogenicity and safety of COVID-19 vaccines in patients with haematological malignancy.
INFECTION CONTROL
|
|
|
12/2/21
|
Qomara WF, Primanissa DN, Amalia SH, et al. | Int J Gen Med
Aim: To summarize the clinical effectiveness and safety of remdesivir, favipiravir, and lopinavir/ritonavir on COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/2/21
|
Rindi LV, Moghazi SA, Donno DR, et al. | Int J Infect Dis
Aim: To summarize the literature on predicting rules for PE in hospitalized COVID-19 patients (HCPs).
CLINICAL CHARACTERISTICS
|
|
|
12/2/21
|
Pakzad R, Malekifar P, Shateri Z, et al. | J Clin Lab Anal
Aim: To evaluate the pathogens' coinfection prevalence among COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/1/21
|
Lin Z, Niu J, Xu Y, et al. | J Med Virol
Aim: To determine the clinical efficacy and adverse events of baricitnib in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/1/21
|
Granata G, Petrosillo N, Al Moghazi S, et al. | Anaerobe
Aim: To assess the proportion of confirmed COVID-19 patients with Clostridioides difficile infection (CDI) and to describe risk factors and outcome of these patients.
CLINICAL CHARACTERISTICS
|
|
|
12/1/21
|
Imtiaz S, Nafeh F, Russell C, et al. | Subst Abuse Treat Prev Policy
Aim: To review the evidence on the impact of COVID-19 on drug overdose-related deaths.
MENTAL HEALTH
|
|
|
11/30/21
|
Ismail II, Salama S | J Neuroimmunol
Aim: To systematically review the reported cases of CNS demyelination in association with COVID-19 vaccination
INFECTION CONTROL
|
|
|
11/30/21
|
Chen X | Glob Health J
Aim: To review the evidence on COVID-19 prevention, control, and treatment.
INFECTION CONTROL
|
|
|
11/30/21
|
Siahaan YMT, Ketaren RJ, Hartoyo V, et al. | Epilepsy Behav
Aim: To analyze whether patients with epilepsy have an increased risk of having poor COVID-19 outcomes.
CLINICAL CHARACTERISTICS
|
|
|
11/30/21
|
Mazidimoradi A, Hadavandsiri F, Momenimovahed Z, et al. | J Gastrointest Cancer
Aim: To investigate the effects of COVID-19 pandemic on the diagnosis and treatment of colorectal cancer.
INFECTION CONTROL
|
|
|
11/30/21
|
Zuin M, Rigatelli G, Quadretti L, et al. | Infect Dis Rep
Aim: To assess the prevalence and mortality risk in COVID-19 patients with anemia.
CLINICAL CHARACTERISTICS
|
|
|
11/30/21
|
Eyles E, Moran P, Okolie C, et al. | J Affect Disord Rep
Aim: To review the evidence of the impact of the COVID-19 pandemic on the mental health of healthcare and social care workers, and its potential effect on suicidal thoughts and behaviour.
MENTAL HEALTH
|
|
|
11/30/21
|
Iftikhar S, Rehman AU, Ameer MZ, et al. | Ann Med Surg
Aim: To review the evidence on COVID-19-related-PRES from both clinical and pathophysiological standpoint.
CLINICAL CHARACTERISTICS
|
|
|
11/29/21
|
Yusof W, Irekeola AA, Wada Y, et al. | Life
Aim: To provide a global mutational profile of SARS-CoV-2 from December 2019 to October 2020. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/29/21
|
Torres Neto L, Monteiro MLG, Galvan D, et al. | Pharmaceuticals
Aim: To identify the most promising EO compounds and potential EO sources against COVID-19 based on their affinity by target proteins, drug-likeness, bioactivity score, and ADME/T.
CANDIDATE THERAPEUTICS
|
|
|
11/29/21
|
Ciuffreda G, Cabanillas-Barea S, Carrasco-Uribarren A, et al. | Int J Environ Res Public Health
Aim: To explore the possible factors associated with depression and anxiety during the COVID-19 pandemic in a population older than 60 years.
MENTAL HEALTH
|
|
|
11/29/21
|
Vargas M, Marra A, Buonanno P, et al. | J Clin Med
Aim: To investigate the impact of corticosteroids on mortality in ARDS in both COVID-19 and non-COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
11/29/21
|
Hussain S, Riad A, Singh A, et al. | J Fungi
Aim: To compute the pooled prevalence of CAM and other associated clinical outcomes.
CLINICAL CHARACTERISTICS
|
|
|
11/29/21
|
Sagris D, Florentin M, Tasoudis P, et al. | J Clin Med
Aim: To investigate the potential beneficial effect of immunomodulation therapy on the thromboembolic risk in hospitalized COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/29/21
|
Yu M, Wang DC, Li S, et al. | J Med Virol
Aim: To systematically evaluate the efficacy and safety of Arbidol and lopinavir/ritonavir (LPV/r) in the treatment of coronavirus disease 2019(COVID-19) using a meta-analysis method.
CANDIDATE THERAPEUTICS
|
|
|
11/29/21
|
Wu HHL, Kalra PA, Chinnadurai R | Vaccines
Aim: To delineate the range of kidney histopathologies that were elicited following COVID-19 vaccination. UPDATED
INFECTION CONTROL
|
|
|
11/29/21
|
Lieneck C, Ramamonjiarivelo Z, Cox J, et al. | Healthcare
Aim: To systematically identify the facilitators and barriers experienced by outpatient health care organizations in an effort to maintain effective and efficient patient throughput during the pandemic.
INFECTION CONTROL
|
|
|
11/29/21
|
Etemadifar M, Nouri H, Maracy MR, et al. | Rev Neurol
Aim: To gather, synthesize, and meta-analyze data regarding the risk factors associated with a severe course of COVID-19 among patients with multiple sclerosis (pwMS).
CLINICAL CHARACTERISTICS
|
|
|
11/29/21
|
Hayawi K, Shahriar S, Serhani MA, et al. | Vaccines
Aim: To compare the efficacy of COVID-19 vaccines against new variants.
INFECTION CONTROL
|
|
|
11/26/21
|
Khanijahani A, Iezadi S, Gholipour K, et al. | Int J Equity Health
Aim: To systematically review the evidence on the association of racial/ethnic and socioeconomic status (SES) with health outcomes and access to healthcare services during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
11/26/21
|
Santura I, Kawalec P, Furman M, et al. | Pol J Radiol
Aim: To compare chest CT diagnostic test parameters with RT-PCR (reference) in the early diagnosis of COVID-19.
DIAGNOSTICS
|
|
|
11/25/21
|
Kim HB, Kim JH, Wolf BJ | Eur j Clin Pharmacol
Aim: To exhaustively demonstrate the effect of acid suppression treatments on the risk of COVID-19.
INFECTION CONTROL
|
|
|
11/25/21
|
Rotshild V, Hirsh-Raccah B, Miskin I, et al. | Sci Rep
Aim: To compare the efficacy of new COVID-19 vaccines to prevent symptomatic and severe disease in the adult population and to prevent symptomatic COVID-19 among the elderly. UPDATED
INFECTION CONTROL
|
|
|
11/25/21
|
Iezadi S, Gholipour K, Azami-Aghdash S, et al. | PLoS ONE
Aim: To examine the effects of NPHIs on the COVID-19 case growth rate, death growth rate, Intensive Care Unit (ICU) admission, and reproduction number in countries, where NPHIs have been implemented. UPDATED
INFECTION CONTROL
|
|
|
11/25/21
|
Zhang C, Chu H, Pei YV, et al. | Front Glob Womens Health
Aim: To evaluate the effects of COVID-19 among SARS-CoV-2-positive pregnant women in late pregnancy and neonates with SARS-CoV-2-positive pregnant mothers using blood assays to find indicators of maternal and neonatal complications.
CLINICAL CHARACTERISTICS
|
|
|
11/25/21
|
Behnood SA, Shafran R, Bennett SD, et al. | J Infect
Aim: To estimate the prevalence of persistent symptoms following SARS-CoV-2 infection compared with uninfected controls and to identify potential risk factors associated with development of post-COVID symptoms in CYP.
CLINICAL CHARACTERISTICS
|
|
|
11/25/21
|
Senia P, Vella F, Mucci N, et al. | Exp Ther Med
Aim: To analyze the causes of mortality associated with SARS-CoV-2 infection in general, with particular focus on the result of infection in a professional environment.
CLINICAL CHARACTERISTICS
|
|
|
11/24/21
|
Acuff SF, Strickland JC, Tucker JA, et al. | Psychol Addict Behav
Aim: To examine changes in alcohol consumption during the coronavirus disease (COVID-19) pandemic. UPDATED
|
|
|
11/24/21
|
Kaushal K, Kaur H, Sarma P, et al. | J Crit Care
Aim: To evaluate serum ferritin level in different severity levels in COVID-19. UPDATED
DIAGNOSTICS
|
|
|
11/23/21
|
Guven DC, Sahin TK, Kilickap S, et al. | Front Oncol
Aim: To evaluate the antibody responses to COVID-19 in cancer patients.
CLINICAL CHARACTERISTICS
|
|
|
11/23/21
|
Axfors C, Janiaud P, Schmitt AM, et al. | BMC Infect Dis
Aim: To assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/23/21
|
Shekaraiah S, Suresh K | J Voice
Aim: To explore the effect of various masks on voice production parameters.
INFECTION CONTROL
|
|
|
11/23/21
|
Asif AA, Hussain H, Senthil Kumaran S, et al. | J Community Hosp Intern Med Perspect
Aim: To assess efficacy of subcutaneous IFN-beta in regards to mortality and discharge rate.
CLINICAL CHARACTERISTICS
|
|
|
11/23/21
|
Ahmad S, Sohail A, Shahid Chishti MA, et al. | J Taibah Univ Med Sci
Aim: To determine whether the prevalence of OGD is sufficiently high in COVID-19 to justify their use as screening tools for this disease.
CLINICAL CHARACTERISTICS
|
|
|
11/23/21
|
Conway R, Grimshaw AA, Konig MF, et al. | Arthritis Rheumatol
Aim: To quantify the risk for SARS-CoV-2 infection and describe clinical outcomes of COVID-19 in people with RMD. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/23/21
|
Xu W, Li X, Dong Y, et al. | J Glob Health
Aim: To investigate the extent of SARS-CoV-2 transmission in schools. UPDATED
INFECTION CONTROL
|
|
|
11/22/21
|
Meng Y, Wang J, Wen K, et al. | Biomed Res Int
Aim: To present systematic reviews and detailed estimates of the major symptoms of COVID-19, determine the prevalence of serious comorbidities, and assess patient progression via comorbidities, major symptoms and laboratory examination to help severe patients and effectively reduce the mortality of COVID-19 under the condition of limited medical resources. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/22/21
|
Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, et al. | Eur J Cancer
Aim: To assess seroconversion rates based on anti-S IgG titres after partial and complete COVID-19 immunisation among oncological patients compared with non-cancer participants. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/22/21
|
Bourmistrova NW, Solomon T, Braude P, et al. | J Affect Disord
Aim: To examine the long-term mental health impact of COVID-19. UPDATED
MENTAL HEALTH
|
|
|
11/22/21
|
Nagarajan R, Krishnamoorthy Y, Basavarachar V, et al. | J Affect Disord
Aim: To estimate the prevalence of PTSD among the severe cases of COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/22/21
|
Zinellu A, Paliogiannis P, Carru C, et al. | Clin Exp Med
Aim: To investigate serum concentrations of hydroxybutyrate dehydrogenase (HBDH), a combined marker of myocardial and renal injury, in hospitalized COVID-19 patients with different disease severity and survival status. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/22/21
|
Shah S, Gwee SXW, Ng JQX, et al. | Sci Total Environ
Aim: To assess the performance of wastewater surveillance as early warning system of COVID-19 community transmission.
INFECTION CONTROL
|
|
|
11/19/21
|
Ayerbe L, Risco-Risco C, Forgnone I, et al. | J Antimicrob Chemother
Aim: To summarize the available evidence to date on the beneficial and adverse effects of azithromycin in patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/19/21
|
Talic S, Shah S, Wild H, et al. | BMJ
Aim: To review the evidence on the effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality.
|
|
|
11/19/21
|
Nascimento RB, Araujo NS, Silva JC, et al. | Spec Care Dentist
Aim: Evaluate oral manifestations detected in children with MIS-C and KD associated to COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/18/21
|
Amer YS, Titi MA, Godah MW, et al. | J Clin Epidemiol
Aim: To systematically identify and critically assess the clinical practice guidelines (CPGs) for the management of critically ill patients with COVID-19 with the AGREE II instrument. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/18/21
|
Khoshnood RJ, Zali A, Tafreshinejad A, et al. | Neurol Sci
Aim: To update the pooled prevalence of COVID-19 infection in patients with PD.
CLINICAL CHARACTERISTICS
|
|
|
11/18/21
|
Johns G, Samuel V, Freemantle L, et al. | J Affect Disord
Aim: To provide an estimate of the global prevalence of depression and anxiety symptoms among doctors, based on analysis of evidence from the first year of the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
11/18/21
|
Daly SR, V Nguyen A, Zhang Y, et al. | Brain Hemorrhages
Aim: To explore current literature on the association between COVID-19 and intracranial hemorrhage (ICH).
CLINICAL CHARACTERISTICS
|
|
|
11/17/21
|
Dogan O, Tiwari S, Jabbar MA, et al. | Complex Intell Systems
Aim: To describe, analyze and synthesize the studies related to the AI/ML implementations in the COVID-19 outbreak.
INFECTION CONTROL
|
|
|
11/17/21
|
Debi H, Itu ZT, Amin MT, et al. | Expert Rev Endocrinol Metab
Aim: To investigate the association of serum CRP and D-dimer concentration with COVID-19 severity in diabetic and non-diabetic patients.
CLINICAL CHARACTERISTICS
|
|
|
11/17/21
|
Shahsanayi F, Gharibzadeh A, Petrudi NR | Curr Probl Cardiol
Aim: To systematically assess the clinical sequels as well ascardiovascular findings in patients suffering STEMI following Covid-19.
CLINICAL CHARACTERISTICS
|
|
|
11/17/21
|
Ling RR, Sim JJL, Tan FL, et al. | Transfus Med Rev
Aim: To investigate whether convalescent plasma is futile in reducing mortality in patients hospitalized with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/17/21
|
Ramzi ZS | Am J Emerg Med
Aim: To perform a systematic review and meta-analysis on the prevalence of one-year hospital readmissions and post-discharge all-cause mortality in recovered COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
11/17/21
|
Chandan S, Khan SR, Deliwala S, et al. | J Med Virol
Aim: To assess incidence of postvaccination SARS-CoV-2 infection among vaccinated HCWs.
INFECTION CONTROL
|
|
|
11/17/21
|
Tashakori-Miyanroudi M, Souresrafil A, Hashemi P, et al. | Epilepsy Behav
Aim: To investigate the epidemic effect of COVID-19 on increasing the prevalence of mental disorders such as depression, anxiety, and sleep disorders in people with epilepsy (PWE). UPDATED
MENTAL HEALTH
|
|
|
11/17/21
|
Seligman WH, Fialho L, Sillett N, et al. | BMJ Open
Aim: To develop a standardised minimum set of outcomes for clinical care.
CLINICAL CHARACTERISTICS
|
|
|
11/16/21
|
Du P, Chen W, Luo X, et al. | Ann Palliat Med
Aim: To compare the time intervals from onset to first medical visit and onset to the hospitalization of COVID-19 patients in different regions and assess the supply and demand status of medical resources. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/16/21
|
Liu Q, Qin C, Liu M, et al. | Infect Dis Poverty
Aim: To systematically evaluate the effectiveness and safety of COVID-19 vaccines in the real world and to establish a reliable evidence-based basis for the actual protective effect of the COVID-19 vaccines.
INFECTION CONTROL
|
|
|
11/16/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the "test, trace, isolate, and quarantine" strategy advocated by World Health Organization during the COVID-19 pandemic. UPDATED
|
|
|
11/16/21
|
Xie Q, Tang S, Li Y | Ann Palliat Med
Aim: To evaluate the safety and efficacy of administering ACEIs and ARBS to patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/16/21
|
Uaprasert N, Panrong K, Rojnuckarin P, et al. | Thromb J
Aim: To determine whether SARS-CoV-2 vaccines increase the risks of thromboembolism and hemorrhage. UPDATED
INFECTION CONTROL
|
|
|
11/15/21
|
Gutiérrez-Valencia M, Leache L, Librero J, et al. | Transfusion
Aim: To synthesize the evidence on the association between ABO and the risk of COVID-19 infection and prognosis.
CLINICAL CHARACTERISTICS
|
|
|
11/15/21
|
de Medeiros KS, Sarmento ACA, Costa APF, et al. | Int J Gynaecol Obstet
Aim: To clarify the clinical features of COVID-19 and analyze maternal/fetal morbidity and mortality and the obstetric and neonatal outcomes of pregnant patients.
CLINICAL CHARACTERISTICS
|
|
|
11/15/21
|
Chen CC, Lu SC, Bai CH, et al. | Int J Environ Res Public Health
Aim: To evaluate the diagnostic accuracy of antigen tests for SARS-CoV-2.
DIAGNOSTICS
|
|
|
11/15/21
|
González-Monroy C, Gómez-Gómez I, Olarte-Sánchez CM, et al. | Int J Environ Res Public Health
Aim: To assess changes in eating behaviour during the COVID-19 pandemic by establishing a comparison of eating behaviours before and after the outbreak of the pandemic. UPDATED
MENTAL HEALTH
|
|
|
11/15/21
|
Meyer HJ, Wienke A, Surov A | Acad Radiol
Aim: To elucidate the influence of non-pulmonary findings of thoracic computed tomography (CT) on unfavorable outcomes and in-hospital mortality in COVID-19 patients based on a large patient sample.
CLINICAL CHARACTERISTICS
|
|
|
11/15/21
|
Runacres A, Mackintosh KA, Knight RL, et al. | Int J Environ Res Public Health
Aim: To quantify the change in sedentary time during the COVID-19 pandemic and its effect on health outcomes in the general population.
MENTAL HEALTH
|
|
|
11/15/21
|
Roy S, Demmer RT | Transl Res
Aim: To review the evidence on the interplay between impaired glucose regulation, diabetes mellitus and SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
11/15/21
|
Chen JJ, Kuo G, Lee TH, et al. | J Clin Med
Aim: To explore the rate of mortality, intensive care unit admission, invasive mechanical ventilation, acute kidney injury, kidney replacement therapy and graft loss in the adult kidney transplant population with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/15/21
|
Ojha V, Mani A, Mukherjee A, et al. | Abdom Radiol
Aim: To assess the most common CT imaging features of AMI in COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/15/21
|
Arco-Torres A, Cortés-Martín J, Tovar-Gálvez MI, et al. | J Clin Med
Aim: To compile existing knowledge about currently available drug treatments for COVID-19 in pregnant women. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/15/21
|
Maraolo AE, Crispo A, Piezzo M, et al. | J Clin Med
Aim: To compare the use of TCZ with placebo or standard of care (SoC), for the treatment of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/15/21
|
Giesbers S, Goh E, Kew T, et al. | ur J Obstet Gynecol Reprod Biol
Aim: To review the evidence on the effects of pharmacological and non-pharmacological interventions for COVID-19 on maternal and neonatal pregnancy outcomes.
CANDIDATE THERAPEUTICS
|
|
|
11/15/21
|
Tufano A, Rendina D, Abate V, et al. | J Clin Med
Aim: To evaluate the RD of the occurrence of VTE, pulmonary embolism (PE), and deep venous thrombosis (DVT) between COVID-19 and other pulmonary infection cohorts, in particular H1N1, and in an ICU setting.
CLINICAL CHARACTERISTICS
|
|
|
11/12/21
|
Mccabe G, Sahni DS, Ramsaha S | Indian J Community Med
Aim: To review the efficacy of chloroquine and its derivative hydroxychloroquine in the treatment of COVID-19 and also explores the safety profile of these drugs.
|
|
|
11/12/21
|
Asili P, Mirahmad M, Tabatabaei-Malazy O, et al. | Daru
Aim: To critically report the characteristics of all the registered and published randomized clinical trials (RCTs) conducted on COVID-19, and summarize the evaluation of potential therapies developed in various regions.
|
|
|
11/12/21
|
Puri A, He L, Giri M, et al. | Nurs Open
Aim: To evaluate the comorbidities among severe and non-severe COVID-19 patients in Asian versus non-Asian populations.
|
|
|
11/12/21
|
Panda PK, Sharawat IK, Natarajan V, et al. | J Family Med Prim Care
Aim: To provide a pooled estimate of the efficacy of various medications in children with SARS-CoV-2 infection.
|
|
|
11/12/21
|
Magesh S, John D, Li WT, et al. | JAMA Netw Open
Aim: To evaluate the association of race and ethnicity with COVID-19 outcomes and to examine the association between race, ethnicity, COVID-19 outcomes, and socioeconomic determinants.
|
|
|
11/12/21
|
Navari Y, Bagheri AB, Akhavan Rezayat A, et al. | Health Sci Rep
Aim: To provide a model predictor and a risk analysis of mortality in kidney transplant COVID?19 positive patients.
|
|
|
11/12/21
|
| Pan American Health Organization
Aim: To review the evidence on the therapeutic options for COVID-19. UPDATED
|
|
|
11/11/21
|
Ramasamy C, Mishra AK, John KJ, et al. | World J Clin Cases
Aim: To identify contributors of worse outcomes in patients with malignancy and COVID-19 and to describe the role of critical care.
CLINICAL CHARACTERISTICS
|
|
|
11/11/21
|
Kow CS, Ramachandram DS, Hasan SS | Hypertens Res
Aim: To determine the overall effect of the preadmission/prediagnosis use of calcium channel blockers (CCBs) on the clinical outcomes in hypertensive patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/11/21
|
Beran A, Mhanna M, Srour O, et al. | Respir Care
Aim: To evaluate the effectiveness of APP to improve the clinical outcomes in non-intubated subjects with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/11/21
|
Ngamprasertchai T, Kajeekul R, Sivakorn C, et al. | Infect Dis Ther
Aim: To rank immunomodulators in the treatment of COVID-19 according to their efficacy and safety. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/11/21
|
Ahmed F, Abid M, Maniya T, et al. | Eur J Prev Cardiol
Aim: To provide a well-powered comprehensive assessment of the risk and prognosis of COVID-19 in recipients of HT.
CLINICAL CHARACTERISTICS
|
|
|
11/11/21
|
Kannapadi NV, Jami M, Premraj L, et al. | Heart Lung Circ
Aim: To characterise neurological events during ECMO support in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
11/11/21
|
Jafar A, Lasso A, Shorr R, et al. | PLoS One
Aim: To evaluate the extent and timing of olfactory recovery following loss due to COVID-19 infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/11/21
|
Ulloque-Badaracco JR, Hernandez-Bustamante EA, Herrera-Añazco P, et al. | Travel Med Infect Dis
Aim: To assess the prognosis value of apolipoproteins and ApoB/ApoA1 ratio for COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
|
|
|
11/11/21
|
Wijaya I, Andhika R, Huang I, et al. | Clin Epidemiol Glob Health
Aim: To assess the effect of aspirin on the outcome in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/11/21
|
Jefferson T, Spencer EA, Brassey J, et al. | Clin Microbiol Infect
Aim: To determine infectiousness and probable contribution of asymptomatic (at the time of testing) to pandemic SARS-CoV-2 spread.
INFECTION CONTROL
|
|
|
11/11/21
|
Mahmood MM, Jafarli I, Al-Barazanchi AF, et al. | Zhongguo Dang Dai Er Ke Za Zhi
Aim: To describe clinical features of coronavirus disease 2019 (COVID-19) in children with a focus on the possible reasons why children are less susceptible to COVID-19 and whether their immune response works better than adults.
CLINICAL CHARACTERISTICS
|
|
|
11/10/21
|
Nindrea RD, Usman E, Katar Y, et al. | Clin Epidemiol Glob Health
Aim: To find the acceptance of COVID-19 vaccination and correlated variables.
|
|
|
11/10/21
|
Rouva G, Vergadi E, Galanakis E | Acta Paediatr
Aim: To evaluate the rate of acute abdomen and abdominal surgical emergencies in children with MIS-C.
|
|
|
11/10/21
|
Roberts A, Rogers J, Mason R, et al. | Drug Alcohol Depend
Aim: To document and interpret the frequency and severity of alcohol and other substance use during the Covid-19 pandemic and their relationship to demographic and mental health variables. UPDATED
MENTAL HEALTH
|
|
|
11/10/21
|
Varikasuvu SR, Varshney S, Dutt N, et al. | Sci Rep
Aim: To quantify the associations of D-dimer with disease progression in patients with COVID-19.
|
|
|
11/10/21
|
Abdullah EK, Velladath SU, Varghese A, et al. | Clin Epidemiol Glob Health
Aim: To review the evidence on depression and anxiety associated with COVID- 19 pandemic among healthcare professionals in India. UPDATED
MENTAL HEALTH
|
|
|
11/10/21
|
Zanirati G, Provenzi L, Libermann LL, et al. | NPJ Regen Med
Aim: To investigate different types of stem cells as treatments for COVID-19 and ARDS to evaluate the safety and potential efficacy of cell therapy. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/9/21
|
Chen WC, Hsu CK, Chen CY, et al. | Expert Rev Anti Infect Ther
Aim: To investigate the efficacy of interferon (IFN)-beta-containing regimens in treating patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/9/21
|
Maharana A, Amutorine M, Sengeh MD, et al. | Sci Afr
Aim: To review the evidence on the use of technology during the initial wave of the COVID-19 pandemic in most African countries.
INFECTION CONTROL
|
|
|
11/8/21
|
Cau A, Cheng MP, Lee T, et al. | Can J Kidney Health Dis
Aim: To review the evidence on the frequencies of AKI and renal replacement therapy (RRT) in critically ill COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
11/8/21
|
Ebrahimpour L, Marashi M, Zamanian H, et al. | Quant Imaging Med Surg
Aim: To compile the existing data on the CT characteristics of COVID-19 disease in children.
CLINICAL CHARACTERISTICS
|
|
|
11/8/21
|
Fakhrolmobasheri M, Mazaheri-Tehrani S, Kieliszek M, et al. | Biol Trace Elem Res
Aim: To summarize the available data surrounding the association of body selenium levels with the outcomes of COVID-19
CLINICAL CHARACTERISTICS
|
|
|
11/8/21
|
Haussner W, DeRosa AP, Haussner D, et al. | Am J Emerg Med
Aim: To conduct a systematic review of COVID-19-associated myocarditis, including clinical presentation, risk factors, and prognosis.
CLINICAL CHARACTERISTICS
|
|
|
11/8/21
|
Chiu L, Shen M, Lo CH, et al. | PLoS One
Aim: To summarize the current literature and report clinical outcomes on the use of famotidine for treatment of hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/8/21
|
Signorelli C, Odone A, Gianfredi V, et al. | Acta Biomed
Aim: To reconstruct the epidemiological dynamics of the first wave of SARS-CoV-2 infection in the Lombardy Region.
INFECTION CONTROL
|
|
|
11/8/21
|
Pecoraro V, Negro A, Pirotti T, et al. | Eur J Clin Invest
Aim: To estimate the rate of RT-PCR false-negatives at initial testing for COVID-19. UPDATED
DIAGNOSTICS
|
|
|
11/8/21
|
Agyemang C, Richters A, Jolani S, et al. | BMJ Glob Health
Aim: To describe the presence and magnitude of associations between ethnic groups and COVID-19-related outcomes.
CLINICAL CHARACTERISTICS
|
|
|
11/8/21
|
Nejati-Zarnaqi B, Sahebi A, Jahangiri K | J Forensic Legal Med
Aim: To investigate factors affecting the corpse management process of the patients dying of COVID 19.
|
|
|
11/8/21
|
Koontalay A, Suksatan W, Prabsangob K, et al. | J Multidiscip Healthc
Aim: To identify and explore the challenges and burdens of frontline healthcare workers during the current pandemic, and to help prepare workforce support plans for them now and in the future.
MENTAL HEALTH
|
|
|
11/8/21
|
Rostami M, Mansouritorghabeh H, Parsa-Kondelaji M | Clin Environ Med
Aim: To obtain data on the status of the hemostatic factors of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/8/21
|
Singh AK, Singh A, Singh R, et al. | Diabetes Metab Syndr
Aim: To find out the efficacy and safety of molnupiravir in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/8/21
|
Riccò M, Gualerzi G, Ranzieri S, et al. | Acta Biomed
Aim: To explore the occurrence of SARS-CoV-2 infection in HCWs.
INFECTION CONTROL
|
|
|
11/8/21
|
Li M, Yang X, Jiang L, et al. | BMJ Open
Aim: To comprehensively and objectively evaluate the safety and immunogenicity of inactivated SARS-CoV-2 vaccines in healthy individuals. UPDATED
INFECTION CONTROL
|
|
|
11/8/21
|
Souza Botelho M, Bolfi F, Leite RGOF, et al. | Syst Rev
Aim: To evaluate the safety of CQ and HCQ from malarial and non-malarial randomized clinical trials (RCTs). UPDATED
|
|
|
11/8/21
|
Fu W, Sivajohan B, McClymont E, et al. | Int J Gynaecol Obstet
Aim: To summarize the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnancy and lactation. UPDATED
INFECTION CONTROL
|
|
|
11/8/21
|
Byambasuren O, Beller E, Clark J, et al. | Antimicrob Resist Infect Control
Aim: To synthesize all available research on the potential impact of eye protection on transmission of SARS-CoV-2. UPDATED
INFECTION CONTROL
|
|
|
11/8/21
|
Margarucci LM, Enrico M, GIanfranceschi G, et al. | Acta Biomed
Aim: To assess whether low serum 25-OHD is associated with susceptibility to COVID 19, their severity, and mortality. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/8/21
|
Tsang TK, Wang C, Yang B, et al. | Nat Commun
Aim: To extract information on disease severity among index cases and secondary cases identified by contact tracing of index cases for COVID-19.
INFECTION CONTROL
|
|
|
11/8/21
|
Rawat D, Roy A, Maitra S, et al. | Diabetes Metab Syndr
Aim: To find out the impact of Vitamin-C administration on major clinical outcomes (mortality, ICU admission, hospital stay, mechanical ventilation) in patients diagnosed with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/8/21
|
Sofi F, Dinu M, Reboldi G, et al. | Int J Cardiol
Aim: To investigate whether differences in COVID-19 epidemiology or public health-related factors could explain discrepant findings in different countries. UPDATED
|
|
|
11/5/21
|
Chilkoti GT, Mohta M, Saxena AK, et al. | Indian J Crit Care Med
Aim: To investigate the efficacy of prone positioning (PP) in the management of coronavirus disease-2019 (COVID-19) pneumonia in various setups, with various modes of oxygen therapy and its optimal duration.
CANDIDATE THERAPEUTICS
|
|
|
11/5/21
|
Parashar S, Karthik AR, Gupta R, et al. | Indian J Crit Care Med
Aim: To systemically appraise and summarize the available literature regarding the role of awake proning in the management of COVID-19 novel coronavirus pneumonia. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/5/21
|
Li Y, Chen B, Hong Z, et al. | Sleep Med
Aim: To review the evidence on the prevalence of insomnia symptoms during the early and late stages of the COVID-19 pandemic in China, and to determine the prevalence of insomnia symptoms in specific populations during the pandemic.
CLINICAL CHARACTERISTICS
|
|
|
11/5/21
|
Heidarpour M, Abhari AP, Sadeghpour N, et al. | Diabetes Metab Syndr
Aim: To investigate the clinical outcome of COVID-19 in patients with prediabetes UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/5/21
|
Karki SJ, Joachim A, Heinsohn T, et al. | BMJ Open
Aim: To summarise the comparative risk of infection in school staff and their contribution to SARS-CoV-2 transmission. UPDATED
INFECTION CONTROL
|
|
|
11/5/21
|
Addis A, Amato L, Cruciani F, et al. | Front Pharmacol
Aim: To assess the characteristics of the SoC adopted in the published RCTs.
|
|
|
11/5/21
|
Damara FA, Muchamad GR, Ikhsani R, et al. | Diabetes Metab Syndr
Aim: To summarize recent findings on the relationship between thyroid disease and COVID-19 outcome. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/4/21
|
Amanzio M, Mitsikostas DD, Giovannelli F, et al. | Lancet Reg Health Am
Aim: To compare the rates of solicited AEs in the active and placebo groups of SARS-CoV-2 vaccines approved by the Western pharmaceutical regulatory agencies.
INFECTION CONTROL
|
|
|
11/4/21
|
Yang J, D'Souza R, Kharrat A, et al. | Acta Obstet Gynecol Scand
Aim: To review the evidence on pregnancy and neonatal outcomes by comparing the pandemic and pre-pandemic periods.
CLINICAL CHARACTERISTICS
|
|
|
11/4/21
|
Malgie J, Schoones JW, Zeegers MP, et al. | Sci Rep
Aim: To review the evidence on the effectiveness of IL-6 receptor antagonists on patients hospitalized with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/4/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
11/4/21
|
Nikolopoulos M, Maheshwari MK, Doumouchtsis SK, et al. | Arch Gynecol Obstet
Aim: To evaluate the impact of the COVID-19 pandemic on patients with gynaecological cancer and the impact of cancer on the clinical presentation of COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
11/4/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
11/4/21
|
Quincho-Lopez A, Benites-Ibarra CA, Hilario-Gomez MM, et al. | PLoS One
Aim: To assess the prevalence of self-medication for the prevention or management of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/4/21
|
Kim SJ, Cho YJ, Lee DW | Acta Orthop Traumatol Turc
Aim: To evaluate whether COVID-19-related period of societal restrictions and nationwide in 2020 were associated with a significant change in types and frequency of traumatic fractures.
INFECTION CONTROL
|
|
|
11/4/21
|
Vaselli NM, Hungerford D, Shenton B, et al. | PLoS One
Aim: To review the evidence on the seroprevalence of SARS-CoV-2 in Europe. UPDATED
INFECTION CONTROL
|
|
|
11/4/21
|
Hunter J, Arentz S, Goldenberg J, et al. | BMJ Open
Aim: To evaluate the benefits and risks of zinc formulations compared with controls for prevention or treatment of acute viral respiratory tract infections (RTIs) in adults.
CANDIDATE THERAPEUTICS
|
|
|
11/3/21
|
Alrashed F, Battat R, Abdullah I, et al. | BMJ Open Gastroenterol
Aim: To evaluate the association between IBD therapies and severe COVID-19 outcomes.
CLINICAL CHARACTERISTICS
|
|
|
11/3/21
|
Wang Z, Zhao S, Tang Y, et al. | Research Square
Aim: To evaluate the efficacy and safety of using potential drugs: remdesivir and glucocorticoid in treating children and adolescents with COVID-19 and intravenous immunoglobulin (IVIG) in treating MIS-C.
CANDIDATE THERAPEUTICS
|
|
|
11/3/21
|
Hoang MP, Staibano P, McHugh T, et al. | Int Forum Allergy Rhinol
Aim: To assess the sensitivity of self-reporting and psychophysical tests for OGD. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/3/21
|
Lindsay RK, Wilson JJ, Trott M, et al. | Ann Med
Aim: To synthesise the recommendations for returning athletes who have experienced long COVID symptoms. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/2/21
|
Desai HD, Sharma K, Shah A, et al. | J Cosmet Dermatol
Aim: To describe the demographic, clinical, morphological characteristics, outcomes, and timing of development of herpes zoster to the various COVID-19 vaccines. And to identify on whether COVID-19 vaccine has temporal relationship between development of herpes zoster (HZ).
INFECTION CONTROL
|
|
|
11/2/21
|
Kow CS, Javed A, Ramachandram D, et al. | Expert Rev Anti Infect Ther
Aim: To review the evidence on the clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/2/21
|
Thakker RA, Elbadawi A, Chatila KF, et al. | Curr Probl Cardiol
Aim: To review the evidence on the presentation of STEMI patients who have SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
11/2/21
|
Lee JX, Chieng WK, Lau SCD, et al. | Front Med
Aim: To provide an overview of the clinical profile, including the clinical presentations, laboratory, and radiological findings, as well as the outcome of COVID-19 infection among patients with hemoglobinopathy. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/2/21
|
Tripathi K, Godoy Brewer G, Thu Nguyen M, et al. | Inflamm Bowel Dis
Aim: To investigate the epidemiology, clinical characteristics, and outcomes in IBD patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/2/21
|
Chamlagain R, Shah S, Sharma Paudel B, et al. | Interdiscip Perspect Infect Dis
Aim: To assess the role of sarilumab in the treatment of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/2/21
|
Funakoshi K, Morita T, Kumanogoh A | Front Med
Aim: To review the clinical course among intubated survivors, non-survivors, and extracorporeal membrane oxygenation (ECMO) patients to reveal the standard clinical course and the difference among critical COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/2/21
|
Li Z, Shao W, Zhang J, et al. | Front Cardiovasc Med
Aim: To clarify the prevalence and clinical impact of AF and new-onset AF in patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/2/21
|
Corti C, Antonarelli G, Scotté F, et al. | Ann Oncol
Aim: To investigate the current available evidence about the immunogenicity of COVID-19 vaccines in patients with cancer (PsC).
INFECTION CONTROL
|
|
|
11/2/21
|
Khosravizadeh O, Ahadinezhad B, Maleki A, et al. | Int J Risk Saf Med
Aim: To identify social distancing strategies and policies and their impact on the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
11/2/21
|
Pian W, Chi J, Ma F | Inf Process Manag
Aim: To synthesize the existing literature on the causes and impacts of COVID-19 infodemic and to summarize the proposed strategies to fight with COVID-19 infodemic.
INFECTION CONTROL
|
|
|
11/2/21
|
Antony Leo Asser P, Soundararajan K | Work
Aim: To synthesize physiotherapy-related articles to COVID-19 and summarize their efficacious highlights.
CANDIDATE THERAPEUTICS
|
|
|
11/1/21
|
Vandepitte S, Alleman T, Nopens I, et al. | Value Health
Aim: To review the available cost-effectiveness studies on different policy measures to protect, detect, prevent/contain, and treat COVID-19 infections.
INFECTION CONTROL
|
|
|
11/1/21
|
Yaacoub S, Khabsa J, El-Khoury R, et al. | BMC Infect Dis
Aim: To review the evidence on the association between engaging in swimming-related activities and COVID-19 transmission; and the effects of strategies for preventing COVID-19 transmission during swimming-related activities.
INFECTION CONTROL
|
|
|
11/1/21
|
Smith CM, Gilbert EB, Riordan PA, et al. | Gen Hosp Psychiatry
Aim: To describe the comorbidities, presentations, and outcomes of adults with incident psychosis and a history of COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/1/21
|
Hvas CL, Larsen JB, Adelborg K, et al. | Semin Thromb Hemost
Aim: To review the evidence on dynamic hemostasis and fibrinolysis assays in intensive care in COVID-19 patients and association with thrombosis and bleeding.
CLINICAL CHARACTERISTICS
|
|
|
11/1/21
|
Vela D, Vela-Gaxha Z, Rexhepi M, et al. | Br J Clin Pharmacol
Aim: To evaluate the efficacy and safety of tocilizumab versus standard care/placebo in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/1/21
|
Racine N, McArthur BA, Cooke JE, et al. | JAMA Pediatr
Aim: To ascertain more precise estimates of the global prevalence of child and adolescent clinically elevated depression and anxiety symptoms during COVID-19.
MENTAL HEALTH
|
|
|
11/1/21
|
Poudel AN, Zhu S, Cooper N, et al. | PLoS One
Aim: To review the evidence on the impacts of COVID-19 on HRQoL of patients with Covid-19 (confirmed or suspected) and explore the risk factors for reduced HRQoL of Covid-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
11/1/21
|
Vasilevska V, Guest PC, Bernstein HG, et al. | J Neuroinflammation
Aim: To identify published cases of anti-NMDAR encephalitis with concurrent neuropsychiatric symptoms temporally associated with SARS-CoV-2 infections.
CLINICAL CHARACTERISTICS
|
|
|
11/1/21
|
Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, et al. | J Dent Res
Aim: To provide a comprehensive up-to-date summary of oral manifestations in patients with COVID-19. UPDATED
|
|
|
11/1/21
|
Hartmann-Boyce J, Rees K, Perring JC, et al. | Diabetes Care
Aim: To review the evidence regarding the extent to which PWD are at increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or of suffering its complications, including associated mortality. WHO COLLABORATIVE
CLINICAL CHARACTERISTICS
|
|
|
11/1/21
|
Spick M, Lewis HM, Wilde MJ, et al. | Metabolism
Aim: To assess the accuracy of mass spectrometry diagnostic tests developed so far, across a wide range of biological matrices.
DIAGNOSTICS
|
|
|
11/1/21
|
Hou H, Xu J, Li Y, et al. | J Allergy Clin Immunol Pract
Aim: To investigate the association between asthma and the risk for mortality among COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/29/21
|
Sarwar M, Ali Z, Fatima M, et al. | J Clin Lab Anal
Aim: To determine the efficacy of colchicine in optimizing inflammatory hematological biomarker levels among COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
10/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on de-isolation and the risk of infection in people with COVID-19.
|
|
|
10/29/21
|
Sharif N, Alzahrani KJ, Ahmed SN, et al. | Front Immunol
Aim: To review the evidence on the efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines.
INFECTION CONTROL
|
|
|
10/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on adverse foetal and neonatal outcomes associated with COVID-19 infection during pregnancy.
|
|
|
10/29/21
|
Chen JJ, Lee TH, Tian YC, et al. | JAMA Netw Open
Aim: To assess immunogenicity rates in people with end-stage kidney disease (ESKD) receiving SARS-CoV-2 vaccines, explore postvaccination potential risk factors for nonresponse, and assess whether receiving dialysis is associated with different antibody response rates compared with the nondialysis population.
CLINICAL CHARACTERISTICS
|
|
|
10/29/21
|
Appleton R, Williams J, Vera San Juan N, et al. | J Med Internet Res
Aim: To investigate the adoption and impacts of telemental health approaches during the COVID-19 Pandemic, and facilitators and barriers to optimal implementation. UPDATED
|
|
|
10/28/21
|
Pappa S, Chen J, Barnet J, et al. | Psychiatry Clin Neurosci
Aim: To evaluate the prevalence of anxiety, depression and insomnia in the general adult population and healthcare workers (HCWs) in Southeast Asia during the course of the first year of the pandemic.
MENTAL HEALTH
|
|
|
10/28/21
|
Yeahia R, Schefflein J, Chiarolanzio P, et al. | Clin Imaging
Aim: To compile and analyze brain MRI findings in patients with COVID-19 disease and PRES.
CLINICAL CHARACTERISTICS
|
|
|
10/28/21
|
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Diabetol Metab Syndr
Aim: To re-evaluate the association of SARS-CoV-2 and development of DKA and analyse the demographic and biochemical parameters and the clinical outcomes in COVID-19 patients with DKA.
CLINICAL CHARACTERISTICS
|
|
|
10/28/21
|
Belletti A, Campochiaro C, Marmiere M, et al. | Ann Intensive Care
Aim: To review the evidence on the use IL-6 inhibitors to treat COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/28/21
|
Lampsas S, Tsaplaris P, Pantelidis P, et al. | Curr Med Chem
Aim: To understand the global pattern of endothelial biomarkers related to COVID-19 severity.
CLINICAL CHARACTERISTICS
|
|
|
10/27/21
|
Kamal A, Hodson A, Pearce JM | Vaccines
Aim: To identify factors influencing COVID-19 vaccination uptake between minority ethnic groups in the UK. UPDATED
INFECTION CONTROL
|
|
|
10/27/21
|
Yasmin F, Najeeb H, Naeem A, et al. | Diseases
Aim: To report cases of COVID-19 associated mucormycosis (CAM), evaluate characteristics, clinical manifestations, and outcomes of mucormycosis in COVID-19 active or recovered patients.
CLINICAL CHARACTERISTICS
|
|
|
10/27/21
|
Garg I, Hanif H, Javed N, et al. | Infect Dis Rep
Aim: To review the impact of the COVID-19 pandemic on the LGBTQ+ population, reasons for, and recommendations to address vaccine hesitancy.
INFECTION CONTROL
|
|
|
10/27/21
|
Hafeez MU, Ikram M, Shafiq Z, et al. | Clin Appl Thromb Hemost
Aim: To extrapolate thrombotic risk factors, clinical manifestations, and outcomes of patients diagnosed with TTS following the COVID-19 vaccine.
CLINICAL CHARACTERISTICS
|
|
|
10/27/21
|
Mahamat-Saleh Y, Fiolet T, Rebeaud ME, et al. | BMJ Open
Aim: To investigate the association between diabetes, hypertension, body mass index (BMI) or smoking with the risk of death in patients with COVID-19 and to estimate the proportion of deaths attributable to these conditions. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/27/21
|
Zuin M, Rigatelli G, Bilato C, et al. | Viruses
Aim: To review the evidence on the prevalence and mortality risk in COVID-19 patients with MetS.
CLINICAL CHARACTERISTICS
|
|
|
10/27/21
|
Soares RC, Rocha JS, da Rosa SV, et al. | Epidemiol Health
Aim: To conduct a systematic review of COVID-19 related biosafety guidelines for dental clinical practice in early pandemic, focusing on quality assessment.
INFECTION CONTROL
|
|
|
10/27/21
|
Lv M, Luo X, Shen Q, et al. | Vaccines
Aim: To identify the safety, immunogenicity, and protective efficacy of COVID-19 vaccines in children and adolescents.
INFECTION CONTROL
|
|
|
10/27/21
|
Ho TC, Chen YA, Chan HP, et al. | Vaccines
Aim: To summarize the current findings on the safety and immunogenicity of this heterologous vaccination and elucidate their implications against SARS-CoV-2.
INFECTION CONTROL
|
|
|
10/27/21
|
Nehal KR, Steendam LM, Campos Ponce M, et al. | Vaccines
Aim: To estimate the vaccination intention and identify determinants of willingness and hesitancy.
INFECTION CONTROL
|
|
|
10/26/21
|
Ponsford MJ, Ward TJC, Stoneham SM, et al. | Front Immunol
Aim: To investigate the risk of mortality and critical care admission in hospitalised adults with nosocomial COVID-19, relative to adults requiring hospitalisation due to community-acquired infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/26/21
|
Shahsavarinia K, Ghojazadeh M, Ghabousian A, et al. | Anesth Pain Med
Aim: To investigate the clinical efficacy and cardiac toxicity of hydroxychloroquine or chloroquine with or without azithromycin in the setting of COVID-19 infection.
CANDIDATE THERAPEUTICS
|
|
|
10/26/21
|
Ataei M, Shirazi FM, Nakhaee S, et al. | Environ Sci Pollut Res Int
Aim: To review the evidence related to fabric masks' effectiveness and various fabrics against coronavirus.
INFECTION CONTROL
|
|
|
10/26/21
|
Mayo M, Potugari B, Bzeih R, et al. | Mayo Clin Proc Innov Qual Outcomes
Aim: To assess the impact of measures designed to mitigate the spread of COVID-19 on worldwide cancer screening. UPDATED
INFECTION CONTROL
|
|
|
10/26/21
|
van Hattum JC, Spies JL, Verwijs SM, et al. | BMJ Open Sport Exerc Med
Aim: To provide a comprehensive overview of myocardial and pericardial involvement after SARS-CoV-2 infection, long-term cardiac sequelae after infection and risks of sudden cardiac arrest/sudden cardiac death (SCA/SCD) in athletes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/26/21
|
Ho QY, Sultana R, Lee TL, et al. | Singapore Med J
Aim: To examine the presenting features, outcomes and the effect of treatment on outcomes of KTRs with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/26/21
|
Silva MT, Galvao TF, Chapman E, et al. | Implement Sci
Aim: To assess the effects of dissemination interventions to improve healthcare workers' adherence with IPC guidelines for respiratory infectious diseases in the workplace.
INFECTION CONTROL
|
|
|
10/26/21
|
Li W, Huang Z, Tan B, et al. | J Orthop Translat
Aim: To review the evidence on low-dosage glucocorticoid associated osteonecrosis in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/26/21
|
Freiberg A, Horvath K, Hahne TM, et al. | Bundesgesundheitsblatt
Aim: To review the evidence on the effects of mask-wearing for preventing infectious diseases on the psychosocial development of children and adolescents. UPDATED
MENTAL HEALTH
|
|
|
10/26/21
|
Scquizzato T, Landoni G, Scandroglio AM, et al. | Eur J Emerg Med
Aim: To assess outcomes of SARS-CoV-2 patients with out-of-hospital cardiac arrest. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/26/21
|
Guo T, Jiang F, Liu Y, et al. | Front Mol Biosci
Aim: To determine the respiratory outcomes in patients following COVID-19-related hospitalization.
CLINICAL CHARACTERISTICS
|
|
|
10/26/21
|
Shi Q, Wang Z, Liu J, et al. | EClinicalMedicine
Aim: To identify the predictors of unfavorable prognosis of COVID-19 in children and adolescents.
CLINICAL CHARACTERISTICS
|
|
|
10/26/21
|
Fakhruddin KS, Haiat A, Ngo HC, et al. | Acta Odontol Scand
Aim: To review the evidence of SARS-CoV-2 in the saliva of asymptomatic individuals.
CLINICAL CHARACTERISTICS
|
|
|
10/26/21
|
Sartori A, Balla A, Agresta F, et al. | Minerva Surg
Aim: To report and to analyze if there is and what is the impact of telemedicine in the surgical practice during COVID-19 pandemic.
INFECTION CONTROL
|
|
|
10/26/21
|
Chai J, Xu H, An N, et al. | Front Pediatr
Aim: To identify the confirmed prevalence of depression and anxiety problems for Chinese children and adolescents during home confinement.
MENTAL HEALTH
|
|
|
10/25/21
|
Bloodstream Infections in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Ippolito M, Simone B, Filisina C, et al. | Microorganisms
Aim: To estimate the pooled occurrence of BSIs among hospitalized patients with COVID-19 and mortality of this patient population.
CLINICAL CHARACTERISTICS
|
|
|
10/25/21
|
Gómez G, Basagoitia A, Burrone MS, et al. | Front Psychiatry
Aim: To appraise the characteristics of child-focused, post-crisis interventions to inform return-to-school programs.
MENTAL HEALTH
|
|
|
10/25/21
|
Middleton P, Hsu C, Lythgoe MP | Hepatology
Aim: To assess the reported clinical outcomes of patients with cirrhosis who develop COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
10/25/21
|
Nam SH, Nam JH, Kwon CY | Int J Environ Res Public Health
Aim: To assess psychological and mental impact among vulnerable populations during the COVID-19 pandemic compared to healthy controls.
MENTAL HEALTH
|
|
|
10/25/21
|
Morello W, Vianello FA, Proverbio E, et al. | Pediatr Nephrol
Aim: To describe the severity of all SARS-CoV-2 infections reported in children with INS, to evaluate the risk of new onset and relapses associated with SARS-CoV-2 infection, and to draw recommendations on their management and vaccination.
CLINICAL CHARACTERISTICS
|
|
|
10/25/21
|
Borsche L, Glauner B, von Mendel J | Nutrients
Aim: To collect further evidence on whether low D3 is caused by the infection or if deficiency negatively affects immune defense.
CANDIDATE THERAPEUTICS
|
|
|
10/25/21
|
Monteleone AM, Cascino G, Barone E, et al. | Curr Psychiatry Rep
Aim: To collect evidence regarding the impact of the SarsCov-2 pandemic on people affected by eating disorders (EDs) targeting the following variables: psychopathology changes, mechanisms of vulnerability or resilience, and perception of treatment modifications during the pandemic.
MENTAL HEALTH
|
|
|
10/25/21
|
Martins CPV, Xavier CSF, Cobrado L | J Hosp Infect
Aim: To review the evidence on the efficacy of several disinfection methods against SARS-CoV-2.
INFECTION CONTROL
|
|
|
10/25/21
|
Kumar S, Saurabh MK, Narasimha VL, et al. | Clin Drug Invest
Aim: To determine the efficacy of interferon-beta among moderate-to-severe COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/25/21
|
Parvu V, Gary DS, Mann J, et al. | Front Microbiol
Aim: To assess the diagnostic accuracy of SARS-CoV-2 antigen detection in COVID-19 symptomatic and asymptomatic individuals compared to quantitative reverse transcription polymerase chain reaction (RT-qPCR) and summarizes antigen test sensitivity using meta-regression. UPDATED
DIAGNOSTICS
|
|
|
10/25/21
|
de Araujo CM, Guariza-Filho O, Gonçalves FM, et al. | Int Arch Occup Environ Health
Aim: To analyze the effectiveness of the use of PPE in closed environments, in situations similar to waiting rooms or examination rooms of healthcare facilities, in the face of exposure to a bioaerosol. UPDATED
INFECTION CONTROL
|
|
|
10/25/21
|
Mattey-Mora PP, Begle CA, Owusu CK, et al. | Rev Med Virol
Aim: To systematically assess COVID-19 patient background characteristics and pre-existing comorbidities associated with hospitalisation status. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/25/21
|
Sahni S, Gupta G, Sarda R, et al. | Diabetes Metab Syndr
Aim: To highlight the impact of cardio-metabolic comorbidities on COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
|
|
|
10/25/21
|
Chen J, Farah N, Dong RK, et al. | Int J Environ Res Public Health
Aim: To estimate the pooled prevalence of anxiety, depression, and insomnia in Africa during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
10/25/21
|
Kaul R, Paul P, Kumar S, et al. | Int J Mol Sci
Aim: To analyze the effects of flavonoids on various key SARS-CoV-2 targets.
CANDIDATE THERAPEUTICS
|
|
|
10/25/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk factors associated with severe COVID-19 outcomes in children 12 years and under.
|
|
|
10/25/21
|
Podury S, Srivastava S, Khan E, et al. | Brain Sci
Aim: To review the data on CNS and PNS inflammatory disorders in COVID-19 with respect to CSF, serum and neuroimaging markers. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/25/21
|
Lo Muzio L, Ambosino M, Lo Muzio E, et al. | Int J Environ Res Public Health
Aim: To carry out a systematic search of literature on the SARS-CoV-2 reinfection in order to understand the success of the global vaccine campaigns.
INFECTION CONTROL
|
|
|
10/25/21
|
Chang TH, Chen YC, Chen WY, et al. | Nutrients
Aim: To investigate the impact of lockdown on body weight in the pediatric population.
INFECTION CONTROL
|
|
|
10/22/21
|
Shamshirsaz AA, Hessami K, Morain S, et al. | Am J Perinatol
Aim: To assess the level of intent to receive COVID-19 vaccination and demographical factors influencing vaccine uptake among pregnant individuals.
INFECTION CONTROL
|
|
|
10/22/21
|
Yang Z, Wang X, Wan XG, et al. | Pediatr Pulmonol
Aim: To understand the relationship between the COVID-19 pandemic and asthma outcomes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/22/21
|
Abedi N | J Educ Health Promot
Aim: To investigate the psychological causes and effects of the COVID-19 epidemic outbreak on dentists.
|
|
|
10/22/21
|
Ilonze OJ, Ballut K, Rao RS, et al. | Heart Fail Rev
Aim: To identify the clinical features, outcomes, and immunosuppression strategies of heart transplant recipients with COVID-19 infection.
|
|
|
10/22/21
|
Kreuzberger N, Hirsch C, Chai KL, et al. | Cochrane Database Syst Rev
Aim: To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs for treating patients with COVID-19, compared to an active comparator, placebo, or no intervention.
|
|
|
10/22/21
|
Farooq S, Tunmore J, Ali W, et al. | Psychiatry Res
Aim: To systematically review the evidence about suicide, self-harm and suicidal ideation during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
10/22/21
|
Tanni SE, Bacha HA, Naime A, et al. | J Bras Pneumol
Aim: To review the evidence on the use of hydroxychloroquine for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection and in the treatment of patients with mild COVID-19 in terms of hospitalization, adverse events, and mortality.
|
|
|
10/20/21
|
Frazer K, Mitchell L, Stokes D, et al. | BMJ Open
Aim: To investigate measures implemented in LTCF to reduce transmission of COVID-19 and their effect on morbidity and mortality of residents, staff and visitors.
INFECTION CONTROL
|
|
|
10/20/21
|
Wang L, Zhang Y, Wang D, et al. | Front Med
Aim: To review the application of Artificial Intelligence (AI) techniques in COVID-19, especially for diagnosis, estimation of epidemic trends, prognosis, and exploration of effective and safe drugs and vaccines. UPDATED
DIAGNOSTICS
|
|
|
10/20/21
|
Ullah I, Sohail A, Shah MUFA, et al. | Ann Med Surg
Aim: To summarize the evidence on patients diagnosed with central retinal vein occlusion (CRVO) secondary to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/20/21
|
Mikolajewska A, Fischer AL, Piechotta V, et al. | Cochrane Database Syst Rev
Aim: To assess the effectiveness and safety of Colchicine as a treatment option for COVID-19 in comparison to an active comparator, placebo, or standard care alone in any setting.
CANDIDATE THERAPEUTICS
|
|
|
10/20/21
|
Landolf KM, Lemieux SM, Rose C, et al. | Pharmacotherapy
Aim: To comprehensively evaluate the literature surrounding corticosteroid use in ARDS (non-COVID-19 and COVID-19) in addition to a narrative review of clinical considerations of corticosteroid use in these patient populations.
CANDIDATE THERAPEUTICS
|
|
|
10/20/21
|
Mahapure KS, Prabhune AS, Chouvhan AV | Asian J Neurosurg
Aim: To provide an overview of acute disseminating encephalomyelitis, a potential and serious complication of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/20/21
|
Trimboli P, Cappelli C, Croce L, et al. | Front Endocrinol
Aim: To evaluate the clinical characteristics of SAT.
CLINICAL CHARACTERISTICS
|
|
|
10/20/21
|
Au WY, Cheung PPH | Lancet Microbe
Aim: To assess the performance of three common nucleic acid tests, namely digital PCR (dPCR), quantitative PCR (qPCR), and loop-mediated isothermal amplification (LAMP), to detect SARS-CoV-2 in clinical settings.
DIAGNOSTICS
|
|
|
10/20/21
|
Miniati M, Marzetti F, Palagini L, et al. | Front Psychol
Aim: To summarize current literature studies on COVID pandemic and EDs.
CLINICAL CHARACTERISTICS
|
|
|
10/20/21
|
Veronese N, Saccaro C, Demurtas J, et al. | Ageing Res Rev
Aim: To investigate the prevalence of unwillingness and the uncertainty to vaccinate against COVID-19 in older people and the factors that can be associated with the unwillingness to vaccinate.
INFECTION CONTROL
|
|
|
10/20/21
|
Ouma OK, Ephraim K, Loyce N, et al. | BMJ Open
Aim: To determine the diagnostic test accuracy, cost-effectiveness and utility of laboratory test strategies for COVID-19 in low-income and middle-income countries. UPDATED
DIAGNOSTICS
|
|
|
10/20/21
|
Rocha YM, de Moura GA, Desidério GA, et al. | Z Gesundh Wiss
Aim: To evaluate the impact of the media and the media during the pandemic caused by the new coronavirus, and to determine how the spread of infodemic impacts people’s health. UPDATED
MENTAL HEALTH
|
|
|
10/20/21
|
Yitbarek GY, Walle Ayehu G, Asnakew S, et al. | SAGE Open Med
Aim: To explore CRP in the context of COVID-19 pathogenesis and assess how its level changes with the severity of the disease.
CLINICAL CHARACTERISTICS
|
|
|
10/18/21
|
Pearce LA, Vaisey A, Keen C, et al. | Health Justice
Aim: To identify, collate, and summarise guidance for the prevention and control of COVID-19 in custodial settings in the first six months of 2020. UPDATED
INFECTION CONTROL
|
|
|
10/18/21
|
Li J, Liao X, Zhou Y, et al. | BMC Infect Dis
Aim: To evaluate this potential effect from glucocorticoids treatment for COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/18/21
|
d'Ettorre G, Cacciola EG, Santinelli L, et al. | J Med Virol
Aim: To evaluate the evidence on the working capacity and the relationship life of surviving COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/18/21
|
Harder T, Külper-Schiek W, Reda S, et al. | Euro Surveill
Aim: To assess the extent to which COVID-19 vaccines are able to prevent symptomatic and asymptomatic infections to guide public health recommendations and develop strategies for fully vaccinated people. UPDATED
INFECTION CONTROL
|
|
|
10/18/21
|
Li Z, Li Q, Wang X, et al. | Cancer Med
Aim: To compare the efficacy and safety of HATACE with monotherapy.
INFECTION CONTROL
|
|
|
10/18/21
|
Luo W, Liu X, Bao K, et al. | J Neurol
Aim: To explore the characteristics of ischemic stroke after SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
10/18/21
|
| CADTH
Aim: To review the evidence on post-COVID-19 condition.
|
|
|
10/18/21
|
Mulyadi M, Tonapa SI, Luneto S, et al. | Nurse Educ Pract
Aim: To identify the prevalence of mental health problems and sleep disturbances among nursing students during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
10/18/21
|
Momenimovahed Z, Salehiniya H, Hadavandsiri F, et al. | Front Psychol
Aim: To investigate the psychological distress, type of psychological problem, prevalence, causes and effects of these problem on cancer patients during COVID-19 pandemic.
MENTAL HEALTH
|
|
|
10/18/21
|
Ching SM, Ng KY, Lee KW, et al. | PLoS One
Aim: To determine the prevalence of depression, anxiety, stress, burnout, fear and low resilient among HCPs as well as its associated factors during the COVID-19 pandemic in Asia.
MENTAL HEALTH
|
|
|
10/18/21
|
Crocamo C, Bachi B, Calabrese A, et al. | Neursci Biobehav Res
Aim: To evaluate the association between individual features and depressive symptoms reported by HCWs during the pandemic.
MENTAL HEALTH
|
|
|
10/18/21
|
Yaghoubi M, Salimi M, Meskarpour-Amiri M | Int J Health Plann Manage
Aim: To assess existing evidence on the effects of COVID-19 on healthcare workers (HCWs) using the health-related productivity loss approach.
MENTAL HEALTH
|
|
|
10/18/21
|
Behrmann JT, Blaabjerg J, Jordansen J, et al. | J Atten Disord
Aim: To provide a systematic review of evidence regarding the COVID-19's impact on mental health of individuals with ADHD during the COVID-19 lockdown. UPDATED
MENTAL HEALTH
|
|
|
10/15/21
|
Ferreto LED, Bortoloti DS, Fortes PCN, et al. | Sao Paulo Med J
Aim: To compile results from randomized clinical trials on the effect of dexamethasone, compared with standard treatment for management of SARS-CoV-2.
CANDIDATE THERAPEUTICS
|
|
|
10/15/21
|
Deana NF, Seiffert A, Aravena-Rivas Y, et al. | Int J Environ Res Public Health
Aim: To determine the principal recommendations for reducing exposure to SARS-CoV-2 and the risk of infection in the dental clinic setting.
INFECTION CONTROL
|
|
|
10/15/21
|
Cao H, Ming L, Chen L, et al. | Front Med
Aim: To evaluate the clinical efficacy and safety of CCP for the COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/15/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effectiveness, immunogenicity, and safety of COVID-19 vaccines in persons who have had a prior, confirmed COVID-19 infection. UPDATED
|
|
|
10/14/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of molnupiravir for the treatment for COVID-19.
|
|
|
10/14/21
|
Dorri M, Bazargany MHM, Khodaparast Z, et al. | J Affect Disord Rep
Aim: To summarize the available evidence on the reduced HRQoL and the prevalence of psychiatric problems, including PTSD, depression and anxiety, and HRQoL among COVID-19 survivors. UPDATED
MENTAL HEALTH
|
|
|
10/14/21
|
Pramana Witarto A, Samarta Witarto B, Er Putra AJ, et al. | Iran Biomed J
Aim: To assess the role of serum KL-6 in reflecting the severity of lung injury in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/14/21
|
Groff D, Sun A, Ssentongo AE, et al. | JAMA Netw Open
Aim: To estimate organ system-specific frequency and evolution of PASC.
CLINICAL CHARACTERISTICS
|
|
|
10/14/21
|
Kyriakoulis KG, Kollias A, Poulakou G, et al. | J Clin Med
Aim: To review the impact of anakinra on the outcomes of hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/14/21
|
Jayant K, Reccia I, Bachul PJ, et al. | J Clin Med
Aim: To better understand the clinical course of COVID-19 in kidney transplant recipients and to identify factors associated with clinical outcomes and mortality. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/14/21
|
Harapan H, Fajar JK, Supriono S, et al. | Rev Med Virol
Aim: To determine the prevalence, predictors and outcomes of ALI among patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/14/21
|
Szarpak L, Filipiak KJ, Gasecka A, et al. | Cardiol J
Aim: To summarize the studies published to date regarding the vitamin D supplementation to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive patients.
CANDIDATE THERAPEUTICS
|
|
|
10/13/21
|
Feduniw S, Modzelewski J, Kajdy A, et al. | J Psychosom Obstet Gynaecol
Aim: To investigate the impact of anxiety on the mental health of pregnant women exposed to catastrophic events as compared to those without such exposure.
MENTAL HEALTH
|
|
|
10/13/21
|
Hirschfeld AS | Neurol Neurochir Pol
Aim: To systematically review scientific reports presenting patients with hyperkinetic movement disorders as one of the neurological symptoms.
CLINICAL CHARACTERISTICS
|
|
|
10/13/21
|
Chong WH, Saha BK, Medarov BI | J Intensive Care Med
Aim: To compare the clinical characteristics between COVID-19 survivors and nonsurvivors requiring ECMO support. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/13/21
|
Peters A, Lotfinejad N, Palomo R, et al. | Antimicrob Resist Infect Control
Aim: To assess the microbiological efficacy of decontamination methods of N95/FFP2 respirators. UPDATED
INFECTION CONTROL
|
|
|
10/13/21
|
Misra S, Kolappa K, Prasad M, et al. | Neurology
Aim: To summarize the frequency of neurological manifestations reported in COVID-19 patients and investigate the association of these manifestations with disease severity and mortality.
CLINICAL CHARACTERISTICS
|
|
|
10/13/21
|
Lu H, Shi Y, Chen K, et al. | J Zhejiang Univ Sci B
Aim: To provide a comprehensive perspective into the association between anticancer regimens and the outcomes of cancer patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/13/21
|
Ariyo K, Canestrini S, David AS, et al. | BMJ Open
Aim: To explore patient-assessed quality of life (QoL) in ICU survivors before the COVID-19 pandemic. UPDATED
|
|
|
10/12/21
|
Mirmoeeni S, Azari Jafari A, Hashemi SZ, et al. | J Cardiovasc Thorac Res
Aim: To determine the rates of CVDs in COVID-19 patients based on the incidence proportion of cardiac manifestations, laboratory findings, and related comorbidities.
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
Gandhi G, Thimmappa L, Upadhya N, et al. | Int J Dent Hyg
Aim: To find the efficacy of oral rinses on virucidal property against n-coronavirus (in vivo studies).
CANDIDATE THERAPEUTICS
|
|
|
10/12/21
|
Jiménez-Ruiz CA, López-Padilla D, Alonso-Arroyo A, et al. | Arch Bronconeumol
Aim: To review the evidence on whether tobacco use in COVID-19 patients associated with a negative progression and adverse outcome of the disease.
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of COVID-19 vaccine booster shots.
|
|
|
10/12/21
|
Özgüç S, Kaplan Serin E, Tanriverdi D | Omega
Aim: To compile studies on death anxiety associated with coronavirus disease, list the general characteristics of these studies through descriptive summaries, and combine findings on the level of death anxiety associated with coronavirus disease through meta-analysis.
MENTAL HEALTH
|
|
|
10/12/21
|
Sanfilippo F, Martucci G, La Via L, et al. | Artif Organs
Aim: To summarize the evidence regarding HP therapy in COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/12/21
|
Agouridis AP, Pagkali A, Zintzaras E, et al. | Atheroscler Plus
Aim: To systematically address all the relevant evidence of the association between high-density lipoprotein cholesterol (HDL-C) and COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
Sinha A, Bhaskar SMM | Int Forum Allergy Rhinol
Aim: To estimate the prevalence of mucormycosis amongst hospitalized COVID-19, and COVID-19 among hospitalized mucormycosis patients.
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
Ge L, Zhu H, Wang Q, et al. | J Evid Based Med
Aim: To develop a living evidence-based guideline of integrating Chinese and western medicine for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/12/21
|
Zhu Z, Xu L, Chen G | Hum Vaccin Immunother
Aim: To compare gender differences in the efficacy of COVID-19 vaccination.
INFECTION CONTROL
|
|
|
10/12/21
|
Mahat RK, Rathore V, Singh N, et al. | Clin Nutr ESPEN
Aim: To evaluate the association of lipid parameters (total cholesterol, HDL-cholesterol, LDL-cholesterol, and triacylglycerols) with the severity and mortality in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
Sandler CX, Wyller VBB, Moss-Morris R, et al. | Open Forum Infect Dis
Aim: To review the evidence on post-COVID fatigue.
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
Deal A, Halliday R, Crawshaw AF, et al. | Lancet Infect Dis
Aim: To identify studies on vaccine-preventable disease outbreaks (measles, mumps, rubella, diphtheria, pertussis, polio, hepatitis A, varicella, Neisseria meningitidis , and Haemophilus influenzae ) involving migrants residing in the EU/EEA and Switzerland.
|
|
|
10/12/21
|
Udomkarnjananun S, Kerr SJ, Townamchai N, et al. | Sci Rep
Aim: To systematically analyze published evidence for risk factors associated with mortality in COVID-19 KTR.
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
Shrestha DB, Budhathoki P, Raut S, et al. | World J Virol
Aim: To analyze the rate of new-onset diabetes in COVID-19 patients and compare their clinical outcomes with those of other COVID-19 patients who had normal or increased blood sugar levels or a pre-existing diagnosis of diabetes. UPDATED
|
|
|
10/12/21
|
Vlieg-Boerstra B, de Jong N, Meyer R, et al. | Allergy
Aim: To evaluate the evidence for prevention of any RTI in the general population considered healthy through supplementation with nutrients that already have a recognized role in immune function.
CANDIDATE THERAPEUTICS
|
|
|
10/12/21
|
Renaud-Charest O, Lui LMW, Eskander S, et al. | J Psychiatr Res
Aim: To synthesize the extant evidence reporting on the frequency and factors associated with depression in post-COVID-19 syndrome. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
Jain A, Taneja S | Oral Maxillofac Surg
Aim: To collate and evaluate the data to enable clinicians to understand the disease pattern and types of mycosis and provide meticulous management of these infections in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
Soetedjo NNM, Iryaningrum MR, Damara FA, et al. | Clin Nutr ESPEN
Aim: To evaluate the prognostic properties of hypoalbuminemia for poor prognosis and factors that may influence the relationship. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/12/21
|
Quiros JR, Ross-Comptis J, Hathaway D 3rd, et al. | Infect Chemother
Aim: To examine the efficacy and tolerability of ruxolitinib for adult COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
10/12/21
|
Debeuf R, Swinnen E, Plattiau T, et al. | J Rehabil Med
Aim: To summarize the effects of physical therapy in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
10/12/21
|
Musa MJ, Yousef M, Adam M, et al. | Curr Med Imaging
Aim: To conduct a systematic review reported from a number of studies to show the usefulness of [LUS] and point of care ultrasound for diagnosing COVID-19.
DIAGNOSTICS
|
|
|
10/12/21
|
Sanfilippo F, Tigano S, La Rosa V, et al. | Braz J Anesthesiol
Aim: To evaluate the influence of wearing PPE as compared to standard uniform regarding time-to-intubation (TTI) and success rate.
INFECTION CONTROL
|
|
|
10/12/21
|
Wu X, Li W, Qin Z, et al. | Medicine
Aim: To evaluate the efficacy and safety of TCM assisted in conventional treatment in the treatment of mild and common COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/8/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the published risk mitigation and models of care for COVID-19 positive people in an acute mental health inpatient unit or in the community.
|
|
|
10/8/21
|
Dos Santos ERR, Silva de Paula JL, Tardieux FM, et al. | World J Clin Cases
Aim: To evaluate the relationship between COVID-19 and anxiety experienced in the general population, during the period of social isolation.
MENTAL HEALTH
|
|
|
10/8/21
|
Vaughan M, Trott M, Sapkota R, et al. | J Hum Nutr Diet
Aim: To review the literature examining the changes in 25(OH)D in different types of vitamin D supplementation from randomised controlled trials in this population.
CANDIDATE THERAPEUTICS
|
|
|
10/8/21
|
Sodeifian F, Seyedalhosseini ZS, Kian N, et al. | Front Med
Aim: To examine DILI in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/8/21
|
Almeida ILL, Rego JF, Teixeira ACG, et al. | Rev Paul Pediatr
Aim: To analyze the effects of social isolation on children's and teenagers' development, with emphasis on the possible impacts over their physical and mental health.
MENTAL HEALTH
|
|
|
10/8/21
|
Wake AD | Glob Pediatr Health
Aim: To determine the acceptance rate toward COVID-19 vaccine in Africa.
INFECTION CONTROL
|
|
|
10/8/21
|
Vaccaro C, Mahmoud F, Aboulatta L, et al. | BMC Pregnancy Childbirth
Aim: To evaluate the impact of COVID-19 lockdowns on the incidence of low birth weight (LBW), preterm birth (PTB), and stillbirth.
INFECTION CONTROL
|
|
|
10/7/21
|
Palaiodimou L, Stefanou MI, Katsanos AH, et al. | Neurology
Aim: To systematically evaluate the proportion of CVST among TTS cases and assess its characteristics and outcomes.
INFECTION CONTROL
|
|
|
10/7/21
|
Matta I, Laganà AS, Ghabi E, et al. | Minim Invasive Ther Allied Technol
Aim: To evaluate the risk of SARS-CoV-2 transmission in surgical smoke and aerosols during laparoscopy and open surgery.
INFECTION CONTROL
|
|
|
10/7/21
|
Effectiveness of Contact Tracing for Viral Disease Mitigation and Suppression: Evidence-Based Review
Thomas Craig KJ, Rizvi R, Willis VC, et al. | JMIR Public Health Surveill
Aim: To identify and synthesize evidence regarding the effectiveness of contact tracing on infectious viral disease outcomes.
INFECTION CONTROL
|
|
|
10/7/21
|
Arentz S, Hunter J, Khamba B, et al. | Integr Med Res
Aim: To evaluate the effects of honeybee products compared to controls for the prevention, duration, severity, and recovery of acute viral respiratory tract infections (RTIs), including SARS-CoV-2, in adults and children.
CANDIDATE THERAPEUTICS
|
|
|
10/7/21
|
Guzick AG, Candelari A, Wiese AD, et al. | Curr Psychiatry Rep
Aim: To evaluate the impact of the COVID-19 pandemic on obsessive-compulsive symptoms.
MENTAL HEALTH
|
|
|
10/7/21
|
Ferdous F | Inquiry
Aim: To systematically analyze the impact of COVID-19-related social distancing requirements on older adults living in long-term care facilities (LTCFs).
INFECTION CONTROL
|
|
|
10/6/21
|
Reininghaus EZ, Manchia M, Dalkner N, et al. | Eur Neuropsychopharmacol
Aim: To elucidate the risk and treatment effect of COVID-19 in BD and research on vaccinations in individuals with BD.
CLINICAL CHARACTERISTICS
|
|
|
10/6/21
|
Borges LP, Martins AF, Silva BM, et al. | Int Immunopharmacol
Aim: To analyze scientific articles published in the literature addressing the rapid tests available for COVID-19 diagnosis at the first year of the pandemic.
DIAGNOSTICS
|
|
|
10/6/21
|
Farooq H, Aemaz Ur Rehman M, Asmar A, et al. | J Taibah Univ Med Sci
Aim: To recognize the novel association of IgAN and IgAV with COVID-19 and describe its underlying pathogenesis.
CLINICAL CHARACTERISTICS
|
|
|
10/6/21
|
Kaya MO, Pamukçu E, Yakar B | Epidemiol Health
Aim: To indicate the possible effect of low serum vitamin D (25(OH)D<20 ng/mL or 50nmol/L) on the Covid-19 infection and outcomes.
CANDIDATE THERAPEUTICS
|
|
|
10/6/21
|
| COVID-END
Aim: To review the evidence on the efficacy and effectiveness of available COVID-19 vaccines for variants of concern. UPDATED
|
|
|
10/5/21
|
Robinson E, Sutin AR, Daly M, et al. | J Affect Disord
Aim: To examine the extent to which mental health symptoms changed during the pandemic in 2020, whether changes were persistent or short lived, and if changes were symptom specific.
MENTAL HEALTH
|
|
|
10/5/21
|
Tibubos AN, Otten D, Ernst M, et al. | Front Psychiatry
Aim: To explore whether there are sex- and gender-dependent vulnerabilities to poor mental health outcomes and risk behaviors in the COVID-19 pandemic? UPDATED
MENTAL HEALTH
|
|
|
10/5/21
|
Du XQ, Shi LP, Cao WF, et al. | Front Pharmacol
Aim: To critically evaluate the effectiveness and safety of honeysuckle for COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/5/21
|
Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis
Rahman MM, Bhattacharjee B, Farhana Z, et al. | J Prev Med Hyg
Aim: To estimate the prevalence of all reported symptoms and comorbidities, and then identified the risk factors associated with age of COVID-19 infected patients.
CLINICAL CHARACTERISTICS
|
|
|
10/5/21
|
Patel S, Parikh C, Verma D, et al. | Int J Clin Pract
Aim: To provide a holistic review of our current understanding of COVID-19 induced bowel ischemia.
CLINICAL CHARACTERISTICS
|
|
|
10/5/21
|
Alimohamadi Y, Tola HH, Abbasi-Ghahramanloo A, et al. | J Prev Med Hyg
Aim: To assess the pooled CFR of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/5/21
|
Hammerstein S, König C, Dreisörner T, et al. | Front Psychol
Aim: To review the evidence on the general effect of COVID-19-related school closures in spring 2020 on student achievement in primary and secondary education.
INFECTION CONTROL
|
|
|
10/5/21
|
Kan C, Zhang Y, Han F, et al. | Front Endocrinol
Aim: To assess various antidiabetic agents’ association with mortality in patients with type 2 diabetes (T2DM) who have coronavirus disease 2019 (COVID-19). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/5/21
|
Yin Y, Rohli KE, Shen P, et al. | Prim Care Diabetes
Aim: To summarize epidemiologic evidence of COVID-19 in patients with Type 2 diabetes, explore pathophysiological mechanisms, and integrate recommendations and guidelines for patient management.
CLINICAL CHARACTERISTICS
|
|
|
10/5/21
|
Kyriakopoulos C, Ntritsos G, Gogali A, et al. | Respirology
Aim: To evaluate the efficacy of tocilizumab in the management of hospitalized COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/4/21
|
Kojima N, Shrestha NK, Klausner JD | Eval Health Prof
Aim: To estimate the risk of SARS-CoV-2 reinfection among those previously infected with SARS-CoV-2.
INFECTION CONTROL
|
|
|
10/4/21
|
Wang YH, Wu CC, Bai CH, et al. | J Chin Med Assoc
Aim: To evaluate the diagnostic accuracy of antigen tests for SARS-CoV-2.
DIAGNOSTICS
|
|
|
10/4/21
|
Martins-Filho PR, Pereira de Andrade AL, Pereira de Andrade AJ, et al. | J Clin Neurol
Aim: To describe the clinical features of MFS in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/4/21
|
Yashadhana A, Derbas A, Biles J, et al. | Health Promot Int
Aim: To review articles reporting the perspectives and experiences of pandemic-related discrimination among racially minoritized peoples in high-income contexts.
MENTAL HEALTH
|
|
|
10/4/21
|
Wilairatana P, Masangkay FR, Kotepui KU, et al. | PLoS Negl Trop Dis
Aim: To synthesize, qualitatively and quantitatively, information on the prevalence and characteristics of malaria infection among COVID-19-infected individuals. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/4/21
|
Santenna C, Vidyasagar K, Amarneni KC, et al. | Ther Adv Drug Saf
Aim: To quantify the safety and tolerability of remdesivir, based on safety outcome findings from randomized controlled trials, observational studies and case reports of remdesivir in coronavirus disease 2019 (COVID-19) patients.
CANDIDATE THERAPEUTICS
|
|
|
10/1/21
|
Subramaniam A, Antsey C, Curtis JR, et al. | Research Square
Aim: To evaluate the characteristics, and outcomes of frail patients admitted to ICU with COVID-19.
|
|
|
10/1/21
|
Mehraeen E, Oliaei S, SeyedAlinaghi S, et al. | Infect Disord Drug Targets
Aim: To reflect on the current knowledge and practice of COVID-19 among children.
CLINICAL CHARACTERISTICS
|
|
|
10/1/21
|
Teo KY, Invernizzi A, Staurenghi G, et al. | Am J Ophthalmol
Aim: To evaluate the occurrence of retinal micro-vasculopathy in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and developed coronavirus disease (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
10/1/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the timing of initiation of remdesivir treatment for COVID-19.
|
|
|
10/1/21
|
Sahebi A, Abdi K, Moayedi S, et al. | J Psychosom Res
Aim: To estimate the prevalence of insomnia in healthcare workers. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
Singh P, Singh SP, Verma AK, et al. | Visc Med
Aim: To evaluate key imaging manifestations of COVID-19 on abdominal imaging. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
Aye YN, Mai AS, Zhang A, et al. | QJM
Aim: To evaluate cardiac complications associated with COVID-19 vaccination. UPDATED
INFECTION CONTROL
|
|
|
9/30/21
|
Shah VP, Farah WH, Hill JC, et al. | Open Forum Infect Dis
Aim: To assess the association between CT values and clinical outcomes, including the risk of hospitalization among patients with COVID-19 and the risk of disease severity and death in such patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
Hajure M, Tariku M, Bekele F, et al. | Infect Drug Resist
Aim: To provide the latest assessment of healthcare workers’ attitudes toward the COVID-19 vaccination and its contributing factor worldwide. UPDATED
INFECTION CONTROL
|
|
|
9/30/21
|
Sun P, Luan F, Xu D, et al. | Medicine
Aim: To review the evidence on the impact of the COVID-19 pandemic on immediate breast reconstruction.
INFECTION CONTROL
|
|
|
9/30/21
|
Michelen M, Manoharan L, Elkheir N, et al. | BMJ Glob Health
Aim: To regularly synthesise evidence on long COVID characteristics, to help inform clinical management, rehabilitation strategies and interventional studies to improve long-term outcomes.
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
Jain S, Khanna P, Sarkar S | Monaldi Arch Chest Dis
Aim: To identify the overall incidence of VAP, common organisms associated with it, and outcome in COVID-19 patients in comparison to the non-SARS-CoV-2 infected critically ill ventilated COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
Snow TAC, Saleem N, Ambler G, et al. | Br J Anaesth
Aim: To review the evidence on the use of convalescent plasma in the treatment of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/30/21
|
Attisani L, Pucci A, Luoni G, et al. | J Cardiovasc Surg
Aim: To analyze the outcomes of acute limb ischemia (ALI) in patients suffering from the novel Coronavirus COVID-19 (Sars-Cov-2).
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
Bissacco D, Lomazzi C, Buongiovanni G, et al. | J Cardiovasc Surg
Aim: To present evidence published on COVID-19 and aortic-related issues, highlighting some challenging aspects regarding management, treatment and outcomes.
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
Cavanna L, Citterio C, Toscani I | Vaccines
Aim: To assesse the seroconversion rate and the safety of COVID-19 vaccinations in cancer patients.
INFECTION CONTROL
|
|
|
9/30/21
|
Pérez-Bermejo M, Peris-Ochando B, Murillo-Llorente MT | Nutrients
Aim: To study the impact that the SARS-CoV-2 virus can have on breastfeeding, and whether the virus or antibodies can be transmitted from mother to child through milk.
INFECTION CONTROL
|
|
|
9/30/21
|
Shaterian N, Abdi F, Atarodi Kashani Z, et al. | Arch Acad Emerg Med
Aim: To assess the impact of facemasks and respirators on reducing the spread of respiratory viruses.
INFECTION CONTROL
|
|
|
9/30/21
|
Aggarwal AN, Agarwal R, Dhooria S, et al. | Respir Care
Aim: To evaluate whether asthma increases the risk of severe disease and adverse outcomes among subjects with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
Cruciani M, Pati I, Masiello F, et al. | Diagnostics
Aim: To review the evidence on the use of ivermectin for the treatment and prophylaxis of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/30/21
|
Zhou C, Zhao Y, Wang X, et al. | Pediatr Pulmonol
Aim: To characterize the laboratory parameters of MIS-C compared with those of KD and Kawasaki disease shock syndrome (KDSS). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
Maiese A, Frati P, Del Duca F, et al. | Diagnostics
Aim: To evaluate the current knowledge about postmortem cardiac findings in patients who died of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/30/21
|
Cardwell K, O Murchu E, Byrne P, et al. | Rev Med Virol
Aim: To determine the effectiveness of pharmacological interventions (excluding vaccines) to prevent coronavirus disease 2019 (Covid-19) or reduce the severity of disease.
CANDIDATE THERAPEUTICS
|
|
|
9/30/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence regarding post-acute and subacute care for COVID-19 patients.
|
|
|
9/30/21
|
Ozamiz-Etxebarria N, Idoiaga Mondragon N, Bueno-Notivol J, et al. | Brain Sci
Aim: To update the existing evidence on the prevalence of stress, anxiety, and depression among teachers during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
9/30/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on public health measures to roll out the COVID-19 vaccines.
|
|
|
9/30/21
|
Franchini M, Corsini F, Focosi D, et al. | Diagnostics
Aim: To summarize the evidence from the available systematic reviews on the efficacy and safety of CP in COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/30/21
|
Fan YJ, Chan KH, Hung IF | Vaccines
Aim: To compare the safety and efficacy of 2019 novel coronavirus disease (COVID-19) vaccines according to vaccine platform and severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection severity.
INFECTION CONTROL
|
|
|
9/30/21
|
Januszek SM, Faryniak-Zuzak A, Barna? E, et al. | Medicina
Aim: To conduct a systematic review regarding the approach of pregnant women toward vaccination against COVID-19, with particular regard to determinants of COVID-19 vaccination acceptance.
INFECTION CONTROL
|
|
|
9/30/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of personal protective equipment (PPE) on therapeutic sessions with adults and children who have experienced domestic or family violence, sexual assault, abuse or neglect.
|
|
|
9/30/21
|
Rostami A, Sepidarkish M, Fazlzadeh A, et al. | Clin Microbiol Infect
Aim: To estimate the global and regional SARS-CoV-2 seroprevalences around the world.
INFECTION CONTROL
|
|
|
9/30/21
|
Katsikas Triantafyllidis K, Giannos P, Mian IT, et al. | Vaccines
Aim: To provide an overview of reported cases of VZV reactivation following COVID-19 vaccination.
INFECTION CONTROL
|
|
|
9/30/21
|
Musa SS, Bello UM, Zhao S, et al. | Viruses
Aim: To summarize the evidence from existing systematic reviews about the effects of SARS-CoV-2 infections on maternal perinatal and neonatal outcomes.
CLINICAL CHARACTERISTICS
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effect of COVID-19 on children.
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of oxygen saturation monitors in patient homes to detect COVID-19-associated hypoxia.
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on variable isolation measures for people vaccinated against COVID-19.
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on available treatments for COVID-19 in pregnant patients.
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence regarding temporary workforce reconfigurations such as splitting of teams and establishing social distancing protocols within teams to minimise staff exposure to COVID-19.
|
|
|
9/28/21
|
Chong WH, Saha BK, Neu KP | Infection
Aim: To assess the clinical characteristics and outcomes of patients diagnosed with CAPA compared to those without CAPA. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/28/21
|
Sakthiswary R, Chuah HY, Chiang KS, et al. | Lupus
Aim: To determine the predictors of severe COVID-19 infection in SLE by comparing the mild to moderate cases with the severe to critical ones.
CLINICAL CHARACTERISTICS
|
|
|
9/28/21
|
Perrone F, Balbi M, Casartelli C, et al. | World J Radiol
Aim: To collect, describe, and discuss all the clinical studies evaluating the different CT findings between COVID-19 infection and other infective or non-infective lung diseases.
DIAGNOSTICS
|
|
|
9/28/21
|
Deng J, Zhou F, Ali S, et al. | QJM
Aim: To assess the efficacy and safety of ivermectin for treating COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/28/21
|
Vahedian-Azimi A, Mohammadi SM, Banach M, et al. | Biomed Res Int
Aim: To compare statin use on ICU admission, tracheal intubation, and death outcomes in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
9/28/21
|
Santos RPD, Lordani TVA, Peres LAB, et al. | Nefrologia
Aim: To determine the AKI incidence in patients hospitalized with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/28/21
|
Davey MS, Davey MG, Hurley R, et al. | J Sport Rehabil
Aim: To evaluate the reported rates of return to play (RTP) in conjunction with the expert-derived guidelines previously recommended to enable safe RTP post COVID-19 infection.
INFECTION CONTROL
|
|
|
9/28/21
|
Veys K, Dockx K, Van Remoortel H, et al. | BMC Public Health
Aim: To summarize the effectiveness of community-based hand hygiene promotion programs on infection transmission, health outcomes and behavioral outcomes during epidemic periods in the context of respiratory droplet-transmissible diseases.
INFECTION CONTROL
|
|
|
9/27/21
|
Siemieniuk RA, Bartoszko JJ, Díaz Martinez JP, et al. | BMJ
Aim: To evaluate the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19).
CLINICAL CHARACTERISTICS
|
|
|
9/27/21
|
Rubio-Rivas M, Forero CG, Mora-Luján JM, et al. | Pharmacotherapy
Aim: To summarize evidence about the effect of TCZ to treat severe COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/27/21
|
Lee J, Song JU, Shim SR | J Clin Virol
Aim: To investigate the diagnostic accuracy of rapid antigen detection tests (RADTs) in the diagnosis of SARS-CoV-2 infection.
DIAGNOSTICS
|
|
|
9/27/21
|
Wang JG, Mo YF, Su YH, et al. | Medicine
Aim: To systematically analyze the chest CT imaging features of children with COVID-19 and provide references for clinical practice. UPDATED
DIAGNOSTICS
|
|
|
9/27/21
|
Peng J, Fu M, Mei H, et al. | Rev Med Virol
Aim: To explore the efficacy and safety of immunosuppressants therapy for COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
9/27/21
|
Yin Y, Shi F, Zhang Y, et al. | PLoS One
Aim: To evaluate the reporting quality of randomized controlled trials (RCTs) regarding patients with COVID-19 and analyse the influence factors.
|
|
|
9/27/21
|
Pizzol D, Shin JI, Trott M, et al. | J Endocrinol Invest
Aim: To calculate the pooled prevalence of ED amongst healthcare workers.
CLINICAL CHARACTERISTICS
|
|
|
9/27/21
|
Fernández-de-Las-Peñas C, Navarro-Santana M, Plaza-Manzano G, et al. | Pain
Aim: To synthesize the prevalence of post-COVID pain symptoms of musculoskeletal origin in hospitalized/non-hospitalized patients recovered from SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
9/27/21
|
Gupta S, Padappayil RP, Bansal A, et al. | J Investig Med
Aim: To evaluate the effectiveness of tocilizumab in hospitalized patients with COVID-19 not requiring mechanical ventilation.
CANDIDATE THERAPEUTICS
|
|
|
9/24/21
|
Whear R, Abbott RA, Bethel A, et al. | J Adv Nurs
Aim: To review the evidence on the provision of fundamental nursing care to hospitalized patients with a highly infectious virus and the effectiveness of adaptations to overcome barriers to care. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/24/21
|
Quante M, Brake L, Tolios A, et al. | Transplant Proc
Aim: To produce a current synoptic assessment of mortality and clinical outcomes subsequent to infection and COVID-19 in SOT recipients.
CLINICAL CHARACTERISTICS
|
|
|
9/24/21
|
Sengupta P, Leisegang K, Agarwal A | Arab J Urol
Aim: To provide a concise update on the effects of coronavirus disease 2019 (COVID-19) on male reproduction.
CLINICAL CHARACTERISTICS
|
|
|
9/23/21
|
Keshavarz P, Haseli S, Yazdanpanah F, et al. | Acad Radiol
Aim: To categorize and summarize the imaging data in COVID-19-induced anosmia.
CLINICAL CHARACTERISTICS
|
|
|
9/23/21
|
Konetzka RT, White EM, Pralea A, et al. | J Am Geriatr Soc
Aim: To review the empirical evidence on facility characteristics associated with COVID-19 cases and deaths.
INFECTION CONTROL
|
|
|
9/23/21
|
Fernandez R, Sikhosana N, Green H, et al. | BMJ Open
Aim: To summarise the evidence relating to the prevalence of anxiety and depression among healthcare workers (HCWs) during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
9/23/21
|
Patel P, DeCuir J, Abrams J, et al. | JAMA Netw Open
Aim: To summarize the descriptive epidemiology and clinical characteristics of MIS-A.
CLINICAL CHARACTERISTICS
|
|
|
9/23/21
|
Erbas GS, Botsali A, Erden N, et al. | Int J Dermatol
Aim: To review the evidence on specific manifestations of COVID-19 in the oral mucosa.
CLINICAL CHARACTERISTICS
|
|
|
9/23/21
|
Boet S, Etherington C, Djainai G, et al. | Diving Hyperb Med
Aim: To explore the potential effectiveness and safety of HBOT for treating patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/23/21
|
Srivastava R, Parveen R, Mishra P, et al. | Int J Clin Pract
Aim: To assess the association of venous thromboembolism with severity of COVID-19 disease.
CLINICAL CHARACTERISTICS
|
|
|
9/22/21
|
Lashkari A, Ranjbar R | J Neurovirol
Aim: To review the case studies of COVID-19-related acute cerebrovascular diseases such as ischaemic stroke, intracerebral hemorrhage, and cerebral sinus thrombosis.
CLINICAL CHARACTERISTICS
|
|
|
9/22/21
|
Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, et al. | J Eur Acad Dermatol Venereol
Aim: To assess the prevalence of COVID-19 (diagnosed using PCR and/or serology) in patients with CLL. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/22/21
|
Farrukh L, Mumtaz A, Sana MK | Rev Med Virol
Aim: To study the possibility of re-infection in patients diagnosed with Covid-19, after being discharged from the hospital.
INFECTION CONTROL
|
|
|
9/22/21
|
Wiedenmann M, Goutaki M, Keiser O, et al. | Swiss Med Wkly
Aim: To review the evidence on the role of children and adolescents in the SARS-CoV-2 pandemic, specifically the severity of SARS-CoV-2 presentation, risk of SARS-CoV-2 infection and risk of transmitting SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
9/21/21
|
Giossi R, Menichelli D, Pani A, et al. | Front Pharmacol
Aim: To evaluate the effectiveness of heparin compared to no anticoagulant treatment in reducing overall mortality. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/21/21
|
Hossein Kazemi M, Kuhestani Dehaghi B, et al. | Iran J Med Sci
Aim: To explore the possible association of HScore parameters with severity in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/21/21
|
Rapp A, Fall G, Radomsky AC, Santarossa S | Pediatr Clin North Am
Aim: To review the evidence on the impact of the COVID-19 pandemic on child maltreatment.
MENTAL HEALTH
|
|
|
9/21/21
|
Geng J, Yu X, Bao H, et al. | Front Med
Aim: To determine the predictive value of chronic diseases for the severity and mortality of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/21/21
|
Long Q, Li J, Hu X, et al. | Front Med
Aim: To determine the adverse effects on multiple systems and differences between severe and non-severe patients in the post-acute phase. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/21/21
|
Limen RY, Sedono R, Sugiarto A, | Expert Rev Anti Infect Ther
Aim: To analyze the efficacy of JAK-inhibitors to ameliorate the outcomes of Covid-19 sufferer.
CANDIDATE THERAPEUTICS
|
|
|
9/21/21
|
Porter B, Zile A, Peryer G, et al. | Soc Sci Med
Aim: To: i) synthesise evidence describing the experiences of health and social care staff providing end-of-life care during a disease outbreak or humanitarian disaster, ii) understand the impact on their mental health and wellbeing and, iii) identify means of support. UPDATED
MENTAL HEALTH
|
|
|
9/20/21
|
Diaz-Arocutipa C, Saucedo-Chinchay J, Argulian A | Clin Cardiol
Aim: To review the evidence on the prognostic utility of right ventricular dysfunction (RVD) in patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
9/20/21
|
Zuo L, Ao G, Wang Y, et al. | J Infect
Aim: To investigate the efficacy of BAM in COVID?19.
CANDIDATE THERAPEUTICS
|
|
|
9/20/21
|
Zamani R, Pouremamali R, Rezaei N | Rev Neurosci
Aim: To determine the profile and possible mechanisms behind CNS inflammatory diseases in the context of Covid-19.
CLINICAL CHARACTERISTICS
|
|
|
9/20/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on surging the capacity of emergency departments (EDs) during the COVID-19 pandemic.
|
|
|
9/20/21
|
von Bartheld CS, Hagen MM, Butowt R | ACS Chem Neurosci
Aim: To review the evidence on the role of COVID-19 and genetics on the presentation of anosmia in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/20/21
|
Alemzadeh E, Alemzadeh E, Ziaee M, et al. | Immun Inflamm Dis
Aim: To analyze the correlation between admission to ICU and hospital, disease severity, mortality, D-dimer count, lymphocyte count, and serum calcium levels.
CLINICAL CHARACTERISTICS
|
|
|
9/17/21
|
Chhibber A, Kharat A, Kneale D, et al. | BMC Public Health
Aim: To measure the extent to which COVID-19 related policies reflect equity considerations by focusing on the global policy landscape around wearing masks and personal protection equipment (PPE). UPDATED
INFECTION CONTROL
|
|
|
9/17/21
|
Wang Y, Greenhalgh T, Wardle J, et al. | J Eval Clin Pract
Aim: To evaluate the evidence behind claims that Chinese Herbal Medicine is an effective treatment for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/17/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of COVID-19 vaccines on fertility in men and women.
|
|
|
9/17/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on furloughing (leave of absence from work) and self-isolation of healthcare workers following exposure to COVID-19 and the implications for staffing levels.
|
|
|
9/17/21
|
Vardoulakis S, Espinoza Oyarce DA, et al. | Sci Total Environ
Aim: To assess the risk of transmission of viral or bacterial infections through inhalation, surface contact, and faecal-oral routes in public washrooms in healthcare and non-healthcare environments. UPDATED
INFECTION CONTROL
|
|
|
9/16/21
|
Ghayda RA, Lee KH, Kim JS, et al. | Int J Med Sci
Aim: To document the chest CT findings in patients with confirmed COVID-19 and their association with the clinical severity.
CLINICAL CHARACTERISTICS
|
|
|
9/16/21
|
Martins LA, Santos DVD, Marques PF, et al. | Rev Gaucha Enferm
Aim: To identify in the scientific literature the clinical overview of the pediatric population that tested positive for SARS-CoV-2 and care recommendations and recommendations among children who tested positive for SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
9/16/21
|
Piscoya A, Ng-Sueng LF, Parra Del Riego A, et al. | Arch Med Sci
Aim: To review the benefits and harms of convalescent plasma (CP) in hospitalized COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
9/16/21
|
Siddiquea BN, Shetty A, Bhattacharya O, et al. | BMJ Open
Aim: To assess the knowledge, attitude and practice (KAP) of the global general population regarding COVID-19. UPDATED
INFECTION CONTROL
|
|
|
9/16/21
|
Barceló MA, Saez M | Environ Sci Eur
Aim: To assess the methodological limitations in studies that evaluated the effects of environmental and socioeconomic variables on the spread of COVID-19. UPDATED
INFECTION CONTROL
|
|
|
9/16/21
|
Stratil JM, Biallas RL, Burns J, et al. | Cochrane Database Syst Rev
Aim: To assess the effects of non-pharmacological measures implemented in long-term care facilities to prevent or reduce the transmission of SARS-CoV-2 infection among residents, staff, and visitors.
INFECTION CONTROL
|
|
|
9/15/21
|
Mazzaccaro D, Giannetta M, Fancoli F, et al. | J Cardiovasc Surg
Aim: To review the prevalence, the risk factors and the outcomes of venous thrombosis (VT) in patients hospitalized for COronaVirus Disease 19 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
9/15/21
|
Mawalla WF, Njiro BJ, Bwire GM, et al. | EJHaem
Aim: To gather current evidence on the transmission of SARS?CoV?2 via blood and its derivatives. UPDATED
INFECTION CONTROL
|
|
|
9/15/21
|
Hu H, Ji Z, Feng C, et al. | Integr Med Res
Aim: To analyze the innovativeness and rigorousness of the SR protocols and make recommendations for the design and implementation of future SRs on TCM for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/15/21
|
Ortega-Paz L, Galli M, Capodanno D, et al. | Eur Heart J Cardiovasc Pharmacother
Aim: To review the evidence on the clinical impact of different prophylactic anticoagulation regimens among hospitalized patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/15/21
|
Ming W, Zuo J, Han J, et al. | Eur Arch Otorhinolaryngol
Aim: To analyze the impact of AAD on the severity and mortality of COVID-19 patients and compare clinical outcomes between patients with and without AAD. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/15/21
|
Hesary FB, Salehiniya H | J Gastrointest Cancer
Aim: To investigate the effect of COVID-19 on the diagnosis, treatment, concerns, problems, and mental health of patients with gastric cancer.
MENTAL HEALTH
|
|
|
9/14/21
|
Weiss MJ, Hornby L, Foroutan F, et al. | Transplant Direct
Aim: To create rigorously developed clinical practice recommendations that address the priorities of ODT activity during the pandemic.
INFECTION CONTROL
|
|
|
9/14/21
|
Marasco G, Maida M, Morreale GC, et al. | Can J Gastroenterol Hepatol
Aim: To estimate the rate of gastrointestinal bleeding in COVID-19 patients and its association with mortality.
CLINICAL CHARACTERISTICS
|
|
|
9/14/21
|
Liu L, Ni SY, Yan W, et al. | EClinicalMedicine
Aim: To assess the overall and type-specific risk of mental and neurological disorders for COVID-19 infection and clinical outcomes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/14/21
|
Aragoneses J, Suárez A, Algar J, et al. | Front Med
Aim: To investigate the types of oral manifestations of COVID-19 and their prevalence.
CLINICAL CHARACTERISTICS
|
|
|
9/13/21
|
Razzack AA, Hassan SA, Pasya SKR, et al. | Infect Chemother
Aim: To review the evidence on the effectiveness of remdesivir in critically ill coronavirus disease 2019 (COVID-19) patients.
CANDIDATE THERAPEUTICS
|
|
|
9/13/21
|
Becchetti C, Gschwend SG, Dufour JF, et al. | J Clin Med
Aim: To analyze and summarize the published literature concerning LT recipients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/13/21
|
Jurecka A, Skuci?ska P, G?dek A | Int J Environ Res Public Health
Aim: To review current scientific reports assessing the impact of the pandemic on the physical activity, mental state, and quality of life of professional athletes.
MENTAL HEALTH
|
|
|
9/13/21
|
Prakash J, Bhattacharya PK, Yadav AK, et al. | J Crit Care
Aim: To determine the predictive accuracy of the ROX index for predicting HFNC failure in COVID-19 patients with AHRF. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/13/21
|
Sadjadi M, Mörschel KS, Petticrew M | Eur J Public Health
Aim: To identify factors influencing the acceptability and implementation of social distancing measures.
INFECTION CONTROL
|
|
|
9/13/21
|
de Freitas RF, Torres SC, Martín-Sánchez FJ, et al. | Auton Neurosci
Aim: To systematically review the recent published literature that describes syncope or presyncope as a symptom of COVID-19, having it been observed in the days before or after the diagnosis.
CLINICAL CHARACTERISTICS
|
|
|
9/13/21
|
Mahroum N, Watad A, Bridgewood C, et al. | Int J Environ Res Public Health
Aim: To investigate whether tocilizumab therapy directed against severe COVID-19 improved survival. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/13/21
|
Channa A, Popescu N, Skibinska J, et al. | Sensors
Aim: To review the evidence on ehealth wearables for COVID-19.
DIAGNOSTICS
|
|
|
9/10/21
|
Saniasiaya J, Kulasegarah J, Narayanan P | J Laryngol Otol
Aim: To elucidate olfactory dysfunction amongst children and adolescents with coronavirus disease 2019.
CLINICAL CHARACTERISTICS
|
|
|
9/10/21
|
| Health Quality Ontario
Aim: To determine what is known about REGEN-COV (casirivimab and imdevimab) for the treatment of outpatients or inpatients diagnosed with COVID-19.
|
|
|
9/10/21
|
Heinrich J, Zhao T, Quartucci C, et al. | Gesundheitswesen
Aim: To identify epidemiological studies on the risk of infection with SARS-CoV-2 during travel by train and bus.
INFECTION CONTROL
|
|
|
9/9/21
|
Cascini F, Pantovic A, Al-Ajlouni Y, et al. | EClinicalMedicine
Aim: To review the evidence regarding attitudes and hesitancy to receiving COVID-19 vaccination among the general population in a variety of geographical contexts.
INFECTION CONTROL
|
|
|
9/9/21
|
Zinellu A, Paliogiannis P, Fois AG, et al. | Front Public Health
Aim: To capture and interpret the available evidence regarding the relationship between COVID-19 and lipid profile. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/9/21
|
Li H, Yan B, Gao R, et al. | Int Immunopharmacol
Aim: To assess the effects of corticosteroid therapy for patients with severe coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
9/9/21
|
Billings J, Ching BCF, Gkofa V, et al. | BMC Health Serv Res
Aim: To review the evidence describing healthcare workers’ experiences of working on the frontline and their views about psychosocial support, during COVID-19 or previous pandemics and epidemics, such as Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) or Ebola.
MENTAL HEALTH
|
|
|
9/9/21
|
Eberle C, Stichling S | Diabetol Metab Syndr
Aim: To examine the impact of the COVID-19 lockdown on glycemic control in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D).
INFECTION CONTROL
|
|
|
9/9/21
|
Li Y, Yang X, Yan P, et al. | Front Med
Aim: To explore the impact of metformin use on COVID-19 mortality and other patient-important outcomes across various populations and studies. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/9/21
|
Corica B, Marra AM, Basili S, et al. | Sci Rep
Aim: To evaluate the prevalence of RVD and associated outcomes in patients with COVID-19 UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/9/21
|
Campbell C, Andersson MI, Ansari MA, et al. | Front Med
Aim: To collate data for HBV and TB reactivation, and for complications of active HCV infection.
CANDIDATE THERAPEUTICS
|
|
|
9/9/21
|
Chaudhry MW, Zubair SM, Zubairi ABS, et al. | Adv Respir Med
Aim: To review the evidence on the effectiveness of ivermectin in hospitalized COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
9/9/21
|
Ciapponi A, Bardach A, Mazzoni A, et al. | Vaccine
Aim: To evaluate the effects of COVID-19 vaccines that the COVAX-MIWG selected in August 2020, or their components used in other vaccines, on pregnancy safety outcomes. UPDATED
INFECTION CONTROL
|
|
|
9/9/21
|
Goudarzi S, Esmaeeli S, Valencia JD, et al. | Neurologist
Aim: To recapitulate the available treatments for COVID-19–related GBS and to provide a summary of clinical management strategies for this complication.
CANDIDATE THERAPEUTICS
|
|
|
9/8/21
|
Subramaniam A, Lim ZJ, Ponnapa Reddy M, et al. | Intern Med J
Aim: To investigate the incidence, characteristics, and outcomes of patients who were readmitted to hospital emergency departments or required re-hospitalization following an index hospitalization with a diagnosis of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/8/21
|
Nayeri ND, Nadali J, Divani A, et al. | J Res Med Sci
Aim: To systematically review of symptoms, laboratory and radiologic findings, treatment, and outcomes of patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/8/21
|
Martins-Filho PR, Ferreira LC, Heimfarth L, et al. | Lancet Reg Health Am
Aim: To synthesize the best evidence on the efficacy and safety of HCQ as pre-and post-exposure prophylaxis and treatment of non-hospitalized and hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/8/21
|
Shams Vahdati S, Ala A, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To systematically review the previous systematic reviews which addressed the neurological manifestations of the COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
9/8/21
|
Keng BMH, Gan WH, Tam YC, et al. | JAAD Int
Aim: To determine common PPE-related dermatoses, affected body sites, and implicated occupational contactants. UPDATED
INFECTION CONTROL
|
|
|
9/8/21
|
Wang J, Chen X, Guo Z, et al. | Comput Struct Biotechnol J
Aim: To compare the superspreading potential of SARS, MERS, and COVID-19.
INFECTION CONTROL
|
|
|
9/8/21
|
Tan X, Guo J, Chen Z, et al. | Therap Adv Gastroenterol
Aim: To report on clinical outcomes of COVID-19 patients who underwent GI endoscopy. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/8/21
|
Veronese N, Petrovic M, Benetos A, et al. | Ageing Res Rev
Aim: To investigate whether published and ongoing phase II-III randomized clinical trials evaluating the efficacy of COVID-19 vaccines included a representative sample of older adults.
INFECTION CONTROL
|
|
|
9/8/21
|
Malekifar P, Pakzad R, Shahbahrami R, et al. | Biomed Res Int
Aim: To identify the viral coinfection prevalence among infected people with SARS-CoV-2. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/7/21
|
Sari Motlagh R, Abufaraj M, Karakiewicz PI, et al. | World J Urol
Aim: To assess the risk of SARS-CoV-2 infection and the severity of disease in PCa patients treated with ADT. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/7/21
|
Minh LHN, Abozaid AA, Ha NX, et al. | Rev Med Virol
Aim: To estimate the frequency of clinical symptoms by comparing different clinical presentations based on the severity and living status of the cases.
CLINICAL CHARACTERISTICS
|
|
|
9/7/21
|
Kamarullah W, Sabrina AP, Rocky MA, et al. | Indian Heart J
Aim: To evaluate the effect of the COVID-19 pandemic on the delivery of care systems and clinical outcomes in STEMI patients. UPDATED
INFECTION CONTROL
|
|
|
9/7/21
|
Williams SP, Leong SC | Clin Otolaryngol
Aim: To examine articles which consider either the quantification of risk or strategies to mitigate risk specifically in the setting of rhinological surgery.
INFECTION CONTROL
|
|
|
9/7/21
|
Kim JY, Han K, Suh YJ | J Cardiovasc Magn Reson
Aim: To investigate the prevalence of abnormal CMR findings in recovered COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/7/21
|
Rosca EC, Heneghan C, Spencer EA, et al. | J Travel Med
Aim: To review the evidence on SARS-CoV-2 transmission aboard aircraft, report policy implications, and highlight research gaps requiring urgent attention.
INFECTION CONTROL
|
|
|
9/6/21
|
Ferner RE, Aronson JK | Oxford COVID-19 Evidence Service
|
|
|
9/3/21
|
Mutneja HR, Bhurwal A, Arora S, et al. | Scand J Gastroenterol
Aim: To evaluate whether COVID-19 affects the severity and outcomes associated with acute pancreatitis.
CLINICAL CHARACTERISTICS
|
|
|
9/3/21
|
Wang C, Wen W, Zhang H, et al. | J Am Coll Health
Aim: To study the prevalence of anxiety, depression, and stress in college students during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
9/3/21
|
Bryant A, Lawrie TA, Dowswell T, et al. | Am J Ther
Aim: To assess the efficacy of ivermectin treatment among people with covid-19 infection and as a prophylaxis among people at higher risk of COVID-19 infection. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/3/21
|
Hesaraki M, Akbarizadeh M, Ahmadidarrehsima S, et al. | Rev Environ Health
Aim: To evaluate the knowledge, attitude, practice, and clinical recommendations of health care workers (HCWs) towards COVID-19.
INFECTION CONTROL
|
|
|
9/1/21
|
Voitsidis P, Kerasidou MD, Nikopoulou AV, et al. | Psychiatry Res
Aim: To summarize the scales that have been specifically developed for this reason and are not adaptations of already existing scales.
MENTAL HEALTH
|
|
|
9/1/21
|
Aucoin M, Cardozo V, McLaren MD, et al. | Metab Open
Aim: To identify all research that has assessed changes in levels of cytokines relevant to cytokine storm in response to administration of Echinacea supplementation.
CANDIDATE THERAPEUTICS
|
|
|
9/1/21
|
Sharma AP, Sahoo S, Goyal K, et al. | Andrologia
Aim: To determine the presence of SARS?CoV?2 in the semen of men recovering from COVID?19.
|
|
|
9/1/21
|
Sideli L, Lo Coco G, Bonfanti RC, et al. | Eur Eat Disord Rev
Aim: To examine the pooled prevalence of symptomatic behaviours and mental health deterioration amongst individuals with eating disorders (EDs) and obesity during the COVID-19 confinement.
MENTAL HEALTH
|
|
|
9/1/21
|
Spacey A, Porter S, Board M, et al. | Palliat Med
Aim: To describe and evaluate the impact of the COVID-19 pandemic on end of life care delivery in care homes.
CLINICAL CHARACTERISTICS
|
|
|
9/1/21
|
Rathnayake D, Clarke M, Jayasinghe V. | PLoS One
Aim: To synthesize global evidence on policy strategies with a unique insight to patient prioritisation methods to reduce waiting times for elective surgeries.
INFECTION CONTROL
|
|
|
9/1/21
|
Malik P, Patel K, Pinto C, et al. | J Med Virol
Aim: To evaluate pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS) and conduct meta-regression to evaluate effects of persistent symptoms and ICU admission on poor quality of life.
CLINICAL CHARACTERISTICS
|
|
|
9/1/21
|
Tricco A | SPOR Evidence Alliance
Aim: To examine the control and management of COVID-19, SARS, or MERS in adults 60 years or above living in long-term care facilities.
|
|
|
8/31/21
|
Konwar M, Maurya M, Thatte UM, et al. | Curr Rev Clin Exp Pharmacol
Aim: To analyze the safety data of HCQ against placebo and active treatment in various disease conditions.
CANDIDATE THERAPEUTICS
|
|
|
8/31/21
|
Iheanacho CO, Eze UIH, Adida EA. | Bull Natl Res Cent
Aim: To assess the evidence of “real world” effectiveness of BNT162b2 and ChAdOx1 vaccines in the general populations.
INFECTION CONTROL
|
|
|
8/31/21
|
Wang Q, Zhu H, Li M, et al. | Front Pharmacol
Aim: To evaluate the efficacy and safety of QFPD in patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/31/21
|
Dutta A, Sharma A, Torres-Castro R, et al. | Indian J Psychiatry
Aim: To synthesise the currently available literature on the topic to determine the prevalence of mental health problems in healthcare workers. UPDATED
MENTAL HEALTH
|
|
|
8/31/21
|
Samji H, Wu J, Ladak A, et al. | Child Adolesc Ment Health
Aim: To review existing evidence of the COVID-19 pandemic's global impact on the mental health of children and adolescents <19 years of age and to identify personal and contextual factors that may enhance risk or confer protection in relation to mental health outcomes.
MENTAL HEALTH
|
|
|
8/31/21
|
Wang Y, Wang Y, Huo L, et al. | J Neurol
Aim: To review the evidence on the acute and post-infectious manifestations of SARS-CoV-2-associated ADEM to guide long-term management and health service reorganization.
CLINICAL CHARACTERISTICS
|
|
|
8/31/21
|
Cuevas-Gonzalez MV, Garcia-Perez Á, Gonzalez-Aragon Pineda ÁE, et al. | Biomed Res Int
Aim: To evaluate the role of stem cells against SARS-CoV-2 and COVID-19 in order to identify their potential as a study model and a possible therapeutic source against tissue damage caused by SARS-CoV-2.
CANDIDATE THERAPEUTICS
|
|
|
8/30/21
|
Wang M, Luo X, Wang L, et al. | Diagnostics
Aim: To comprehensively identify the diagnostic agreement between LUS and CT in the diagnosis of interstitial pneumonia caused by COVID-19.
DIAGNOSTICS
|
|
|
8/30/21
|
Freiberg A, Schubert M, Romero Starke K, et al. | Int J Environ Res Public Health
Aim: To investigate whether COVID-19 lockdown influences modifiable cardiovascular risk factors (i.e., physical inactivity, sedentary behaviour, smoking, alcohol use, unhealthy diet, obesity, bad blood lipids, and hypertension) in the general population.
|
|
|
8/30/21
|
Kornitzer J, Johnson J, Yang M, et al. | Int J Environ Res Public Health
Aim: To assess the spectrum of COVID-19 presentation in children, with special emphasis on characteristics associated with multisystem inflammatory syndrome (MIS-C).
CLINICAL CHARACTERISTICS
|
|
|
8/30/21
|
O'Loughlin L, Alvarez Toledo N, Budrie L, et al. | Neurol Int
Aim: To provide an updated review of the current published data on pediatric patients with COVID-19 and coexisting severe neurological manifestations.
CLINICAL CHARACTERISTICS
|
|
|
8/30/21
|
Manzano GS, McEntire CRS, Martinez-Lage M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To synthesize the clinical features of ADEM and AHLE, response to treatments, and clinical outcomes to better understand the nature of this neurologic consequence of COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
8/30/21
|
Abu-Rub LI, Abdelrahman HA, Johar AA, et al. | Antibiotics
Aim: To evaluate the prevalence of antibiotic prescribing in patients admitted to ICUs with SARS-CoV-2 infection.
CANDIDATE THERAPEUTICS
|
|
|
8/30/21
|
Gil Martínez V, Avedillo Salas A, Santander Ballestín S | Pharmaceuticals
Aim: To summarize evidence on the efficacy and safety of five antivirals applied to patients with COVID-19, that have proven to be effective either in vitro studies or in studies on SARS-CoV and MERS.
CANDIDATE THERAPEUTICS
|
|
|
8/30/21
|
Moothedath M, Muhamood M, Bhosale YS, et al. | J Pharm Bioallied Sci
Aim: To summarize if any of the animal models which are being currently used are turning out to be effective host reservoir.
|
|
|
8/30/21
|
Aram K, Patil A, Goldust M, et al. | Dermatol Ther
Aim: To evaluate presentations, post-infection change in the manifestation, diagnosis, and management of flare-ups of underlying dermatologic disease in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/30/21
|
Khandker SS, Nik Hashim NHH, Deris ZZ, et al. | J Clin Med
Aim: To provide an update on the diagnostic accuracy in terms of estimating the specificity and sensitivity of RAT kits in patients with suspected COVID-19. UPDATED
DIAGNOSTICS
|
|
|
8/30/21
|
Madewell ZJ, Yang Y, Longini IM Jr, et al. | JAMA Netw Open
Aim: To examine evidence for household transmission of SARS-CoV-2, disaggregated by several covariates, and to compare it with other coronaviruses. UPDATED
INFECTION CONTROL
|
|
|
8/30/21
|
Salomoni MG, Di Valerio Z, Gabrielli E, et al. | Vaccines
Aim: To systematically review literature on vaccine acceptance, to define more precisely the extent of VH associated with the ongoing vaccination campaign against COVID-19, and thus try to identify subpopulations at increased risk for VH, deserving target strategies.
INFECTION CONTROL
|
|
|
8/30/21
|
Sanchez-Ramirez DC, Normand K, Zhaoyun Y, et al. | Biomedicines
Aim: To explore persistent effects of COVID-19 beyond 3 months follow-up on patient chest computed tomography (CT), lung function, respiratory symptoms, fatigue, functional capacity, quality of life, and the ability to return to work. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/30/21
|
Chen J, Cai Y, Chen Y, et al. | Vaccines
Aim: To calculate the pooled event rate of NMAEs after COVID-19 vaccination. UPDATED
INFECTION CONTROL
|
|
|
8/30/21
|
Treskova-Schwarzbach M, Haas L, Reda S, et al. | BMC Med
Aim: To summarise the evidence on age-adjusted associations between multiple pre-existing health conditions and clearly defined COVID-19 outcomes separating the effects between the geographical regions. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/30/21
|
Rathore SS, Hussain N, Manju AH, et al. | J Med Virol
Aim: To evaluate the correlation between COVID-19 disease and pleural effusion.
CLINICAL CHARACTERISTICS
|
|
|
8/30/21
|
Treglia G, Cuzzocrea M, Giovanella L, et al. | Pharmaceuticals
Aim: To calculate the prevalence of hypermetabolic lymph nodes after COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
8/30/21
|
Lien CH, Lee MD, Weng SL, et al. | Life
Aim: To investigate the effects of colchicine in treating patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/30/21
|
Jena A, Mishra S, Deepak P, et al. | Autoimmune Rev
Aim: To review the evidence on seroconversion after SARS-CoV-2 vaccination in patients with IMIDs and impact of various drugs on seroconversion rates.
|
|
|
8/30/21
|
Amereh F, Negahban-Azar M, Isazadeh S, et al. | Pathogens
Aim: To provide state-of-the-knowledge on the occurrence and existing methods for sampling procedures, detection/quantification of SARS-CoV-2 in sewage samples.
INFECTION CONTROL
|
|
|
8/30/21
|
Bignucolo A, Scarabel L, Mezzalira S, et al. | Vaccines
Aim: To investigate the influence of sex on the efficacy of COVID-19 vaccines.
INFECTION CONTROL
|
|
|
8/30/21
|
Systematic Review on the Mental Health and Treatment Impacts of COVID-19 on Neurocognitive Disorders
Dellazizzo L, Léveillé N, Landry C, et al. | J Pers Med
Aim: To address the mental health effects of COVID-19 on people with NCD in addition to examine the impact of the pandemic on treatments/resources for NCD.
MENTAL HEALTH
|
|
|
8/30/21
|
de Labry-Lima AO, Bermudez-Tamayo C, Martinez-Olmos J, et al. | Enferm Infecc Microbiol Clin
Aim: To compile the available evidence on the use of masks in relation to respiratory infections. UPDATED
INFECTION CONTROL
|
|
|
8/30/21
|
Munro A, Booth H, Gray NM, et al. | Int J Environ Res Public Health
Aim: To inform current and future responses to coronavirus outbreaks by identifying and critically appraising the empirical evidence relating to the impact of novel coronavirus outbreaks of the 21st Century on problem drug users, with a particular focus on COVID-19 UPDATED
INFECTION CONTROL
|
|
|
8/30/21
|
Krzych ?J, Putowski Z, Czok M, et al. | Viruses
Aim: To investigate a possible role of TPE in severe COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/28/21
|
Hariyanto TI, Intan D, Hananto JE, et al. | Diabetes Res Clin Pract
Aim: To evaluate and analyze the association between GLP1-RA and Covid-19 mortality.
INFECTION CONTROL
|
|
|
8/27/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/27/21
|
Ousseiran ZH, Fares Y, Chamoun WT | Int J Neurosci
Aim: To study and summarize the different neurological manifestations of this virus.
CLINICAL CHARACTERISTICS
|
|
|
8/27/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/27/21
|
Sarkar S, Kannan S, Khanna P, et al | J Med Virol
Aim: To explore the utility of PLR as a prognostic predictor of COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/27/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/27/21
|
Picchioni F, Goulao LF, Roberfroid D, et al. | Clin Nutr
Aim: To identify documented effects of COVID-19 on diet quality and nutritional status of children under-5 years and women of childbearing age in LMICs.
|
|
|
8/26/21
|
Caroselli C, Blaivas M, Falzetti S | Ultrasound Med Biol
Aim: To evaluate COVID-19 imaging options in pediatric patients
DIAGNOSTICS
|
|
|
8/26/21
|
Romoli M, Eusebi P, Forlivesi S, et al. | Int J Stroke
Aim: To review and meta-analyze variations in stroke admissions, rate and timing of reperfusion treatments during the 1st-wave COVID pandemic versus the pre-pandemic timeframe depending on stroke network model adopted.
INFECTION CONTROL
|
|
|
8/26/21
|
Qian W, Ye Y, Zuo L, et al. | Immunotherapy
Aim: To quantify the effects of immune checkpoint inhibitors (ICIs) on the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/26/21
|
Saniasiaya J, Prepageran N | J Laryngol Otol
Aim: To outline the impact on quality of life in coronavirus disease 2019 patients with olfactory dysfunction.
CLINICAL CHARACTERISTICS
|
|
|
8/26/21
|
Spoorthy MS, Pratapa SK, Mahant S | Asian J Psychiatr
Aim: To review the literature about mental health problems faced by health care workers (HCW) during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
8/26/21
|
Dykgraaf SH, Matenge S, Desborough J, et al. | J Am Med Dir Assoc
Aim: To review the evidence on strategies to reduce transmission of SARS-CoV-2 in long-term care facilities.
INFECTION CONTROL
|
|
|
8/26/21
|
Banerjee S, Mahapatra AK | Rev Recent Clin Trials
Aim: To review the evidence on the use of tocilizumab for the treatment for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/26/21
|
Barnawi GM, Barnawi AM, Samarkandy S | Cureus
Aim: To assess the prevalence and types of dermatological manifestations associated with wearing PPE for a long time during the COVID-19 pandemic period.
INFECTION CONTROL
|
|
|
8/26/21
|
Kyiakoulis KG, Kollias A, Kyrakoulis IG, et al. | Curr Vasc Pharmacol
Aim: To identify published guidance reports by national and international societies regarding thromboprophylaxis strategies in COVID-19 patients in different settings (outpatients, hospitalized, post-discharge).
CLINICAL CHARACTERISTICS
|
|
|
8/23/21
|
Mistry DA, Wang JY, Moeser M, et al. | BMC Infect Dis
Aim: To assess the sensitivity and specificity of LFDs.
DIAGNOSTICS
|
|
|
8/23/21
|
Du X, Shi L, Cao W, et al. | PLoS One
Aim: To evaluate the add-on effect of CHM in the treatment of mild to moderate COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/23/21
|
Sullivan BN, Fischer T | Front Aging Neurosci
Aim: To gain insight into the types of neurological complications associated with SARS-CoV-2 infection and their possible relationship with age, sex, COVID-19 severity, and comorbidities.
CLINICAL CHARACTERISTICS
|
|
|
8/23/21
|
An W, Kang J, Wang Q, et al. | J Infect Public Health
Aim: To systematically investigate the relationship between cardiac biomarkers and COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
|
|
|
8/23/21
|
Wei Y, Wei L, Liu Y, et al. | Infection
Aim: To estimate the central tendency and dispersion for incubation period of COVID-19 and, in turn, assess the effect of a certain length of quarantine for close contacts in active monitoring.
INFECTION CONTROL
|
|
|
8/23/21
|
Ghorbani SS, Taherpour N, Bayat S, et al. | J Med Virol
Aim: To review the evidence on the frequency and definitions of re-infection rates, recurrence, and hospital readmission following SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
8/23/21
|
Andreas M, Piechotta V, Skoetz N, et al. | Cochrane Database Syst Rev
Aim: To assess the efficacy and safety of pharmacological and non-pharmacological interventions for palliative symptom control in individuals with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/23/21
|
Mental health interventions in healthcare workers in infectious disease outbreak-A systematic review
Zace D, Hoxhaj I, Orfino A, et al. | Eur J Public Health
Aim: To identify strategies to manage mental health issues in healthcare workers during infectious disease outbreaks.
MENTAL HEALTH
|
|
|
8/23/21
|
Buselli R, Corsi M, Veltri A, et al. | Psychiatry Res
Aim: To ascertain the interventions put in place worldwide in reducing stress in HCWs during the COVID-19 outbreak.
MENTAL HEALTH
|
|
|
8/23/21
|
Yan Q, Qiu D, Liu X, et al. | Front Pediatr
Aim: To examine the pooled prevalence of smell or taste dysfunctions among children with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/23/21
|
Wang J, Shi P, Chen D, et al. | Stem Cells Dev
Aim: To review the evidence on the safety and effectiveness of MSCs in the treatment of COVID-19-associated pneumonia patients
CANDIDATE THERAPEUTICS
|
|
|
8/23/21
|
Bhattacharyya A, Sarma P, Sharma DJ, et al. | Indian J Pharmacol
Aim: To review the evidence on COVID-19-associated mucormycosis.
CLINICAL CHARACTERISTICS
|
|
|
8/23/21
|
Mashayekhi F, Sairafianpour F, Mohammad AP, et al. | Int J Clin Pract
Aim: To review the evidence on presentations of severe potential life-threatening skin eruptions in COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/23/21
|
Han T, Ma S, Sun C, et al. | Arch Med Res
Aim: To further explore queries about effects of anti-diabetic agents on mortality and poor composite outcomes of COVID-19 in diabetic patients.
CLINICAL CHARACTERISTICS
|
|
|
8/23/21
|
Oliaei S, SeyedAlinaghi S, Mehrtak M, et al. | Eur J Med Res
Aim: To systematically review the studies discussing hyperbaric oxygen therapy (HBOT) to examine its reported efficacy and adverse events in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/23/21
|
Chiu N, Chi H, Tu Y, et al. | Expert Rev Vaccines
Aim: To review the evidence on the immunogenicity and reactogenicity of heterologous vaccination.
INFECTION CONTROL
|
|
|
8/23/21
|
Prajapat M, Handa V, Sarma P, et al. | Indian J Pharmacol
Aim: To review the different mutation strains (variant of concern [VOC] and variant of interest [VOI]) which were found in different countries such as the UK, Singapore, China, Germany, Vietnam, Western Africa, Dublin, Ireland, Brazil, Iran, Italy, France, America, and Philippines.
INFECTION CONTROL
|
|
|
8/23/21
|
Busch IM, Moretti F, Mazzi M, et al. | Psychotherapy and Psychosomatics
Aim: To comprehensively synthesize and quantify the psychological and psychosomatic symptoms of healthcare providers on the frontline of past epidemics/pandemics (i.e., Ebola, H1N1, SARS, MERS) and the current pandemic (i.e., COVID-19). UPDATED
MENTAL HEALTH
|
|
|
8/20/21
|
Hariyanto TI, Putri C, Hananto JE, et al. | J Psychiatr Res
Aim: To explore the potential association between delirium and poor outcomes from COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/18/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/18/21
|
Kourti A, Stavridou A, Panagouli E, et al. | Trauma Violence Abuse
Aim: To identify the international trends in domestic violence during the COVID-19 epidemic and to examine the possible differences among all population groups and different geographic areas worldwide.
MENTAL HEALTH
|
|
|
8/18/21
|
Tadakamadla J, Boccalari E, Rathore V, et al. | J Infect Public Health
Aim: To evaluate the evidence on the efficacy of mouth rinses on SARS-CoV-2 from in vitro studies.
CANDIDATE THERAPEUTICS
|
|
|
8/18/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/17/21
|
Lee M, Lim H, Xavier MS, et al. | J Relig Health
Aim: To summarize the roles that religious communities played during the early stage of COVID-19 pandemic. UPDATED
|
|
|
8/17/21
|
Finsterer J, Scorza FA, Scorza C, et al. | Bosn J Basic Med Sci
Aim: To summarize and discuss the recent advances concerning the clinical presentation, pathophysiology, diagnosis, treatment, and outcomes of SARS-CoV-2 associated cranial nerve mononeuropathies or polyneuropathies.
CLINICAL CHARACTERISTICS
|
|
|
8/17/21
|
Ridjab DA, Ivan I, Budiman F, et al. | Medicine
Aim: To evaluate risk of PR prolongation, QRS widening, and QT prolongation from lopinavir, ritonavir, atazanavir, and saquinavir.
CANDIDATE THERAPEUTICS
|
|
|
8/17/21
|
Walsh S, Chowdhury A, Braithwaite V, et al. | BMJ Open
Aim: To summarise observational evidence of the effect of school closures and school reopenings on SARS-CoV-2 community transmission. UPDATED
INFECTION CONTROL
|
|
|
8/17/21
|
Kyriazopoulou E, Huet T, Cavalli G, et al. | Lancet Rheumatol
Aim: To assess the effect of anakinra treatment on mortality in patients admitted to hospital with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/17/21
|
Zheng HL, Guo ZL, Wang ML, et al. | Environ Sci Pollut Res Int
Aim: To review the evidence on the association between COVID-19 (coronavirus disease 2019) transmission and meteorological factors.
INFECTION CONTROL
|
|
|
8/17/21
|
Liu CY, Berlin J, Kiti MC, et al. | Epidemiology
Aim: To synthesize empirical data on the changing social contact patterns during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
8/17/21
|
Shanbehzadeh M, Kazemi-Arpanahi H, Kalkhajeh SG, et al. | J Educ Health Promot
Aim: To identify the telemedicine applications in the COVID-19 pandemic (tele-COVID) according to interaction modes, transmission modalities, and disease categories.
INFECTION CONTROL
|
|
|
8/17/21
|
Wagner C, Griesel M, Mikolajewska A, et al. | Cochrane Database Syst Rev
Aim: To assess whether systemic corticosteroids are effective and safe in the treatment of people with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/17/21
|
Li F, Jiang Y, Yue B, et al. | Medicine
Aim: To evaluate the supportive effects of frequently used traditional Chinese medicine (TCM) for the treatment of coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
8/16/21
|
Ismail II, Salama S | J Neurol
Aim: To investigate the available evidence regarding the different types of CNS demyelination in association with SARS-CoV-2 infection, and the proposed pathophysiological mechanisms in these cases.
CLINICAL CHARACTERISTICS
|
|
|
8/16/21
|
Sunjaya AP, Allida SM, Di Tanna GL, et al. | Eur Respir J
Aim: To review the evidence on whether people with asthma at a higher risk of being infected, hospitalised or of poorer clinical outcomes from COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/16/21
|
Zinellu A, Mangoni AA | J Nephrol
Aim: To review the evidence on the effectiveness of serum cystatin C in COVID-19 in treating COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/16/21
|
Karaoulanis SE, Christodoulou NG | Psychiatriki
Aim: To clarify whether patients with schizophrenia spectrum disorders are at greater risk for poor COVID-19 outcomes.
CLINICAL CHARACTERISTICS
|
|
|
8/16/21
|
Walsh KA, Tyner B, Broderick N, et al. | Rev Med Virol
Aim: To summarize the evidence regarding the effectiveness of public health measures at preventing the transmission of SARS-CoV-2 at mass gatherings.
INFECTION CONTROL
|
|
|
8/16/21
|
Cui Y, Sun Y, Sun J, et al. | Infect Dis Ther
Aim: To explore the beneficial effect of corticosteroids, particularly in pulse methylprednisolone use in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/16/21
|
Alsagaff MY, Oktaviono YH, Dharmadjati BB, et al. | J Arrythm
Aim: To evaluate the latest evidence on the association of ECG on admission and the poor outcomes in COVID?19.
CLINICAL CHARACTERISTICS
|
|
|
8/16/21
|
Chekole YA, Abate SM | Ann Med Surg
Aim: To assess the global prevalence and determinants of mental health disorders. UPDATED
MENTAL HEALTH
|
|
|
8/16/21
|
Scquizzato T, D'Amico F, Rocchi M, et al. | Prehosp Emerg Care
Aim: To analyse how the pandemic impacted the system-of-care of out-of-hospital cardiac arrest. UPDATED
INFECTION CONTROL
|
|
|
8/16/21
|
Chawla N, Tom A, Sen MS, et al. | Indian J Psychol Med
Aim: To appraise the literature from across the globe on the psychological impact of COVID-19 and its associated situations, like social isolation and quarantine, on children and adolescents.
MENTAL HEALTH
|
|
|
8/16/21
|
Maiese A, Manetti AC, Bosetti C, et al. | Brain Pathol
Aim: To review the evidence on the neuropathological features of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/16/21
|
Patanavanich R, Glantz SA | BMC Public Health
Aim: To compare the association between smoking and COVID-19 disease progression between unadjusted analyses with adjusted analyses to examine whether smoking is an independent risk factor.
CLINICAL CHARACTERISTICS
|
|
|
8/16/21
|
Abate V, Casoria A, Rendina D, et al. | Semin Thromb Hemost
Aim: To describe the prevalence and the clinical characteristics of SMH in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
8/16/21
|
Brummer LE, Katzenschlager S, Geaddert M, et al. | PLoS One
Aim: To assess the clinical accuracy (sensi-tivity and specificity) of commercially available Ag-RDTs. UPDATED
DIAGNOSTICS
|
|
|
8/16/21
|
Suárez-González A, Rajagopalan J, Livingston G, et al. | EClinicalMedicine
Aim: To examine and summarise the global research evidence describing the effect of Covid-19 isolation measures on the health of people living with dementia. UPDATED
MENTAL HEALTH
|
|
|
8/13/21
|
Kazemi SN, Hajikhani B, Didar H, et al. | PLoS One
Aim: To understand better the potential effects of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on fetal loss in infected mothers presented with abortion following this infection.
CLINICAL CHARACTERISTICS
|
|
|
8/13/21
|
AbdelHamid S, Refaat AA, Benjamin AM, et al. | Environ Sci Pollut Res Int
Aim: To study the impact of host or viral epigenetic modulation on COVID-19 infection susceptibility and/or outcome. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/13/21
|
Llamas M, Garo ML, Giovanella L | Clin Chem Lab Med
Aim: To assess the prognostic role of fT3 serum levels in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/13/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk of transmission of COVID-19 within post-secondary institutions and the strategies to mitigate on-campus outbreaks? UPDATED
|
|
|
8/12/21
|
Sah P, Fitzpatrick MC, Zimmer CF, et al. | Proc Natl Acad Sci USA
Aim: To review the evidence on laboratory-confirmed infections to estimate the percentage of SARS-CoV-2 infections that are truly asymptomatic.
CLINICAL CHARACTERISTICS
|
|
|
8/12/21
|
Kloypan C, Saesong M, Sangsuemoon J, et al. | Eur J Clin Invest
Aim: To investigate the efficacy of CP vs standard treatment/non-CP on clinical outcomes in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
8/12/21
|
Huth SF, Cho S, Robba C, et al. | Front Neurol
Aim: To review the evidence on the neurologic manifestations identified in hospitalised COVID-19 patients and provide a preliminary estimate of disease prevalence.
CLINICAL CHARACTERISTICS
|
|
|
8/12/21
|
Sen S, Kanna NB, Kumar J, et al. | Int Ophthalmol
Aim: To summarize all retinal manifestations secondary to COVID-19 disease recorded till date since the beginning of the pandemic.
CLINICAL CHARACTERISTICS
|
|
|
8/12/21
|
Diaz-Arocutipa C, Melgar-Talavera B, Alvarado-Yarasca A, et al. |
Aim: To examine the effect of statins use on mortality in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
8/12/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the role of daycares and schools in the transmission of COVID-19. UPDATED
|
|
|
8/11/21
|
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. | Sci Rep
Aim: To identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/10/21
|
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Shankar-Hari M, Vale CL, et al. | JAMA
Aim: To estimate the association between administration of IL-6 antagonists compared with usual care or placebo and 28-day all-cause mortality and other outcomes. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/10/21
|
Lazzari C, Rabottini M | Int J Psychiatry Clin Pract
Aim: To review studies that approach the risk of dementia in older people with SIFL.
MENTAL HEALTH
|
|
|
8/10/21
|
Chung EY, Palmer SC, Natale P, et al. | Am J Kidney Dis
Aim: To assess the incidence and outcomes of COVID-19 in people with CKD.
CLINICAL CHARACTERISTICS
|
|
|
8/10/21
|
Yang Y, Cai Z, Zhang J | Front Endocrinol
Aim: To determine the association between insulin injection and the outcomes of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/10/21
|
de Almeida CARPN, de Almeida GARPN, de Carvalho MRCT, et al. | Brazilian Journal of Health Review
Aim: To review the evidence on the mental health aspects of health professionals during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
8/10/21
|
Qian Z, Lu S, Luo X, et al. | Front Med
Aim: To summarize the current existing evidence on the outcome of critically ill patients with COVID-19 as well as to evaluate the effectiveness of clinical interventions.
CLINICAL CHARACTERISTICS
|
|
|
8/10/21
|
Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, et al. | J Neurol Sci
Aim: To review the reported cases of CVST and VITT following the COVID-19 vaccination.
INFECTION CONTROL
|
|
|
8/9/21
|
Athanasios A, Daley I, Patel A, et al. | Eur Neurol
Aim: To review the prevalence of cerebrovascular accident in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
8/9/21
|
Ingram C, Downey V, Roe M, et al. | Int J Environ Res Public Health
Aim: To synthesize evidence assessing the effectiveness of COVID-19 IPC measures implemented in global workplace settings.
INFECTION CONTROL
|
|
|
8/9/21
|
Conti V, Corbi G, Sellitto C, et al. | J Pe |